251
|
Abouammoh N, Alhasan K, Aljamaan F, Raina R, Malki KH, Altamimi I, Muaygil R, Wahabi H, Jamal A, Alhaboob A, Assiri RA, Al-Tawfiq JA, Al-Eyadhy A, Soliman M, Temsah MH. Perceptions and Earliest Experiences of Medical Students and Faculty With ChatGPT in Medical Education: Qualitative Study. JMIR MEDICAL EDUCATION 2025; 11:e63400. [PMID: 39977012 PMCID: PMC11888024 DOI: 10.2196/63400] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/18/2024] [Revised: 11/03/2024] [Accepted: 01/02/2025] [Indexed: 02/22/2025]
Abstract
BACKGROUND With the rapid development of artificial intelligence technologies, there is a growing interest in the potential use of artificial intelligence-based tools like ChatGPT in medical education. However, there is limited research on the initial perceptions and experiences of faculty and students with ChatGPT, particularly in Saudi Arabia. OBJECTIVE This study aimed to explore the earliest knowledge, perceived benefits, concerns, and limitations of using ChatGPT in medical education among faculty and students at a leading Saudi Arabian university. METHODS A qualitative exploratory study was conducted in April 2023, involving focused meetings with medical faculty and students with varying levels of ChatGPT experience. A thematic analysis was used to identify key themes and subthemes emerging from the discussions. RESULTS Participants demonstrated good knowledge of ChatGPT and its functions. The main themes were perceptions of ChatGPT use, potential benefits, and concerns about ChatGPT in research and medical education. The perceived benefits included collecting and summarizing information and saving time and effort. However, concerns and limitations centered around the potential lack of critical thinking in the information provided, the ambiguity of references, limitations of access, trust in the output of ChatGPT, and ethical concerns. CONCLUSIONS This study provides valuable insights into the perceptions and experiences of medical faculty and students regarding the use of newly introduced large language models like ChatGPT in medical education. While the benefits of ChatGPT were recognized, participants also expressed concerns and limitations requiring further studies for effective integration into medical education, exploring the impact of ChatGPT on learning outcomes, student and faculty satisfaction, and the development of critical thinking skills.
Collapse
Affiliation(s)
- Noura Abouammoh
- College of Medicine, King Saud University, Riyadh, Saudi Arabia
- Department of Family and Community Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia
| | - Khalid Alhasan
- College of Medicine, King Saud University, Riyadh, Saudi Arabia
- Pediatric Department, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia
- Department of Kidney and Pancreas Transplant, Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
| | - Fadi Aljamaan
- College of Medicine, King Saud University, Riyadh, Saudi Arabia
- Critical Care Department, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia
| | - Rupesh Raina
- Department of Nephrology, Cleveland Clinic Akron General and Akron Children Hospital, Akron, OH, United States
| | - Khalid H Malki
- College of Medicine, King Saud University, Riyadh, Saudi Arabia
- Research Chair of Voice, Swallowing, and Communication Disorders, Department of Otolaryngology, College of Medicine, King Saud University, Riyadh, Saudi Arabia
| | | | - Ruaim Muaygil
- College of Medicine, King Saud University, Riyadh, Saudi Arabia
- Medical Education Department, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia
| | - Hayfaa Wahabi
- Department of Family and Community Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia
- Evidence-Based Health Care & Knowledge Translation Research Chair, Family & Community Medicine Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia
| | - Amr Jamal
- College of Medicine, King Saud University, Riyadh, Saudi Arabia
- Department of Family and Community Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia
- Evidence-Based Health Care & Knowledge Translation Research Chair, Family & Community Medicine Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia
| | - Ali Alhaboob
- College of Medicine, King Saud University, Riyadh, Saudi Arabia
- Pediatric Department, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia
| | - Rasha Assad Assiri
- Department of Basic Medical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
| | - Jaffar A Al-Tawfiq
- Specialty Internal Medicine and Quality Department, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia
- Infectious Disease Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States
- Infectious Disease Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States
| | - Ayman Al-Eyadhy
- College of Medicine, King Saud University, Riyadh, Saudi Arabia
- Pediatric Department, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia
| | - Mona Soliman
- College of Medicine, King Saud University, Riyadh, Saudi Arabia
- Medical Education Department, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia
| | - Mohamad-Hani Temsah
- College of Medicine, King Saud University, Riyadh, Saudi Arabia
- Pediatric Department, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia
- Evidence-Based Health Care & Knowledge Translation Research Chair, Family & Community Medicine Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia
| |
Collapse
|
252
|
Busse JW, Genevay S, Agarwal A, Standaert CJ, Carneiro K, Friedrich J, Ferreira M, Verbeke H, Brox JI, Xiao H, Virdee JS, Gunderson J, Foster G, Heegsma C, Samer CF, Coen M, Guyatt GH, Wang X, Sadeghirad B, Malam F, Zeraatkar D, Vandvik PO, Zhou T, Xie F, Siemieniuk RAC, Agoritsas T. Commonly used interventional procedures for non-cancer chronic spine pain: a clinical practice guideline. BMJ 2025; 388:e079970. [PMID: 39971339 DOI: 10.1136/bmj-2024-079970] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/21/2025]
Abstract
CLINICAL QUESTION What is the comparative effectiveness and safety of commonly used interventional procedures (such as spinal injections and ablation procedures) for chronic axial and radicular spine pain that is not associated with cancer or inflammatory arthropathy? CURRENT PRACTICE Chronic spine pain is a common, potentially disabling complaint, for which clinicians often administer interventional procedures. However, clinical practice guidelines provide inconsistent recommendations for their use. RECOMMENDATIONS For people living with chronic axial spine pain (≥3 months), the guideline panel issued strong recommendations against: joint radiofrequency ablation with or without joint targeted injection of local anaesthetic plus steroid; epidural injection of local anaesthetic, steroids, or their combination; joint-targeted injection of local anaesthetic, steroids, or their combination; and intramuscular injection of local anaesthetic with or without steroids. For people living with chronic radicular spine pain (≥3 months), the guideline panel issued strong recommendations against: dorsal root ganglion radiofrequency with or without epidural injection of local anaesthetic or local anaesthetic plus steroids; and epidural injection of local anaesthetic, steroids, or their combination. HOW THIS GUIDELINE WAS CREATED An international guideline development panel including four people living with chronic spine pain, 10 clinicians with experience managing chronic spine pain, and eight methodologists, produced these recommendations in adherence with standards for trustworthy guidelines using the GRADE approach. The MAGIC Evidence Ecosystem Foundation provided methodological support. The guideline panel applied an individual patient perspective when formulating recommendations. THE EVIDENCE These recommendations are informed by a linked systematic review and network meta-analysis of randomised trials and a systematic review of observational studies, summarising the current body of evidence for benefits and harms of common interventional procedures for axial and radicular, chronic, non-cancer spine pain. Specifically, injection of local anaesthetic, steroids, or their combination into the cervical or lumbar facet joint or sacroiliac joint; epidural injections of local anaesthetic, steroids, or their combination; radiofrequency of dorsal root ganglion; radiofrequency denervation of cervical or lumbar facet joints or the sacroiliac joint; and paravertebral intramuscular injections of local anaesthetic, steroids, or their combination. UNDERSTANDING THE RECOMMENDATIONS These recommendations apply to people living with chronic spine pain (≥3 months duration) that is not associated with cancer or inflammatory arthropathy and do not apply to the management of acute spine pain. Further research is warranted and may alter recommendations in the future: in particular, whether there are differences in treatment effects based on subtypes of chronic spine pain, establishing the effectiveness of interventional procedures currently supported by low or very low certainty evidence, and effects on poorly reported patient-important outcomes (such as opioid use, return to work, and sleep quality).
Collapse
Affiliation(s)
- Jason W Busse
- Michael G. DeGroote National Pain Centre, McMaster University, Hamilton, ON, Canada
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
- Department of Anesthesia, McMaster University, Hamilton, ON, Canada
| | - Stéphane Genevay
- Division of Rheumatology, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland
| | - Arnav Agarwal
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
| | - Christopher J Standaert
- Department of Physical Medicine and Rehabilitation, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| | - Kevin Carneiro
- Department of Neurosurgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Jason Friedrich
- Department of Physical Medicine and Rehabilitation, University of Colorado School of Medicine, Aurora, CO, USA
| | - Manuela Ferreira
- The University of Sydney, Sydney Musculoskeletal Health and the Kolling Institute, School of Health Sciences, Faculty of Medicine and Health, St Leonards, NSW 2064, Australia
| | - Hilde Verbeke
- Leuven Center for Algology and Pain Management, University Hospitals Leuven, Leuven, Belgium
| | - Jens Ivar Brox
- Department of Physical Medicine and Rehabilitation, Oslo University Hospital Ullevaal, Oslo, Norway
- Institute of Clinical Medicine, Medical Faculty, Oslo University, Oslo, Norway
| | - Hong Xiao
- Department of Pain Management, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | | | - Janet Gunderson
- Chronic Pain Network, McMaster University, Hamilton, Ontario, Canada
| | - Gary Foster
- The Canadian Veterans Chronic Pain Centre of Excellence, Hamilton, ON, Canada
| | - Conrad Heegsma
- The Canadian Veterans Chronic Pain Centre of Excellence, Hamilton, ON, Canada
| | - Caroline F Samer
- Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals
- Faculty of Medicine, University of Geneva, Switzerland
| | - Matteo Coen
- Division of General Internal Medicine, Department of Medicine, University Hospitals of Geneva, University of Geneva, Switzerland
- Unit of Development and Research in Medical Education, Faculty of Medicine, University of Geneva, Geneva, Switzerland
| | - Gordon H Guyatt
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
| | - Xiaoqin Wang
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
| | - Behnam Sadeghirad
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
- Department of Anesthesia, McMaster University, Hamilton, ON, Canada
| | - Faheem Malam
- Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada
| | - Dena Zeraatkar
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
- Department of Anesthesia, McMaster University, Hamilton, ON, Canada
| | - Per O Vandvik
- Department of Medicine, Innlandet Hospital Trust, Gjøvik, Norway
| | - Ting Zhou
- School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China
| | - Feng Xie
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
| | - Reed A C Siemieniuk
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
| | - Thomas Agoritsas
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
- Division of General Internal Medicine, Department of Medicine, University Hospitals of Geneva, University of Geneva, Switzerland
- The MAGIC Evidence Ecosystem Foundation, Oslo, Norway
| |
Collapse
|
253
|
Harscouët P, Chimpaye GN, Kazibwe H, Kabakyenga J, O'Callaghan D, Blake C, Caulfield B, O'Sullivan C. Managing low-back pain in rural Uganda: a qualitative study exploring the perspectives and practices of frontline health workers regarding LBP management in primary care. BMC Musculoskelet Disord 2025; 26:168. [PMID: 39972436 PMCID: PMC11837481 DOI: 10.1186/s12891-024-08164-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/14/2024] [Accepted: 12/06/2024] [Indexed: 02/21/2025] Open
Abstract
BACKGROUND AND AIMS Low-back pain (LBP) is the main cause of years lived with disabilities (YLDs) worldwide and the second cause of YLDs in Uganda. In 2019, it was responsible for 7.4% of global YLDs and 5% of YLDs in Uganda. LBP takes a significant toll on people's quality of life and disproportionately affects lower socioeconomic classes, elders, and women. In rural Uganda, LBP is managed in health centres by clinical officers and nurses with limited resources. This study aims to understand the perspectives and practices of these health workers. METHOD A qualitative design using semi-structured focus-group discussions was employed. Purposive sampling allowed us to identify relevant participants based on their roles as healthcare professionals working in primary care context in rural South-West Uganda. Data was analysed using thematic analysis. FINDINGS LBP is a common and persistent complaint among patients presenting to rural health centres in Uganda. Manual labour and female specific health conditions were deemed to be common causes. There was a strong reliance on medication prescription, coupled with X-ray diagnosis, with little emphasis on education or exercise. Finally, findings highlighted major barriers for patients within the referral system to hospital care or rehabilitation. DISCUSSION Education and training of frontline clinicians in terms of appropriate prescribing and rehabilitation for LBP is crucial. Evidence-based rehabilitation interventions need to be developed and adapted so that they can be delivered within the time and resource constraints of the health workforce, ensuring that they are acceptable and effective to patients in the context of rural Uganda.
Collapse
Affiliation(s)
- Paul Harscouët
- University College Dublin, Health Sciences Centre, 4 Stillorgan Rd.,, Belfield, Dublin 4, Ireland.
| | - Gloria Ndekezi Chimpaye
- School of Physiotherapy, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda
| | - Herman Kazibwe
- School of Physiotherapy, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda
| | - Jerome Kabakyenga
- Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda
| | - Denise O'Callaghan
- University College Dublin, Health Sciences Centre, 4 Stillorgan Rd.,, Belfield, Dublin 4, Ireland
| | - Catherine Blake
- University College Dublin, Health Sciences Centre, 4 Stillorgan Rd.,, Belfield, Dublin 4, Ireland
| | - Brian Caulfield
- University College Dublin, Health Sciences Centre, 4 Stillorgan Rd.,, Belfield, Dublin 4, Ireland
| | - Cliona O'Sullivan
- University College Dublin, Health Sciences Centre, 4 Stillorgan Rd.,, Belfield, Dublin 4, Ireland.
| |
Collapse
|
254
|
Steinauer A, Marvin W, Barnett NR. Profoundly Delayed Emergence due to Pulmonary Embolism. Case Rep Anesthesiol 2025; 2025:6691273. [PMID: 40007968 PMCID: PMC11858700 DOI: 10.1155/cria/6691273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2024] [Accepted: 01/24/2025] [Indexed: 02/27/2025] Open
Abstract
Pulmonary embolism is a rare, but serious, potential perioperative complication and crisis. We present a case of a 12-year-old female undergoing distal femoral and proximal tibial osteotomies with internal fixations who experienced acute onset hypercapnia, tachycardia, and prolonged minimal responsiveness following deflation of the tourniquet and cessation of inhaled sevoflurane. CT-chest demonstrated bilateral partially occlusive filling defects of the pulmonary vasculature. We concluded that the patient experienced a pulmonary embolism resulting in V/Q mismatch, retained sevoflurane, and ultimately delayed emergence.
Collapse
Affiliation(s)
- Allison Steinauer
- Department of Pediatrics, University of North Carolina Health, Chapel Hill, North Carolina, USA
| | - Whitney Marvin
- Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA
| | - Natalie R. Barnett
- Department of Anesthesia and Perioperative Medicine, Medical University of South Carolina, Charleston, South Carolina, USA
| |
Collapse
|
255
|
Al-Nafjan A, Alshehri H, Aldayel M. Objective Pain Assessment Using Deep Learning Through EEG-Based Brain-Computer Interfaces. BIOLOGY 2025; 14:210. [PMID: 40001978 PMCID: PMC11851851 DOI: 10.3390/biology14020210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/17/2025] [Revised: 02/11/2025] [Accepted: 02/13/2025] [Indexed: 02/27/2025]
Abstract
Objective pain measurements are essential in clinical settings for determining effective treatment strategies. This study aims to utilize brain-computer interface technology for reliable pain classification and detection. We developed an electroencephalography-based pain detection system comprising two main components: (1) pain/no-pain detection and (2) pain severity classification across three levels: low, moderate, and high. Deep learning models, including convolutional neural networks and recurrent neural networks, were employed to classify the wavelet features extracted through time-frequency domain analysis. Furthermore, we compared the performance of our system against conventional machine learning models, such as support vector machines and random forest classifiers. Our deep learning approach outperformed the baseline models, achieving accuracies of 91.84% for pain/no-pain detection and 87.94% for pain severity classification, respectively.
Collapse
Affiliation(s)
- Abeer Al-Nafjan
- Computer Science Department, College of Computer and Information Sciences, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11432, Saudi Arabia
| | - Hadeel Alshehri
- Computer Science Department, College of Computer and Information Sciences, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11432, Saudi Arabia
| | - Mashael Aldayel
- Information Technology Department, College of Computer and Information Sciences, King Saud University, Riyadh 11543, Saudi Arabia
| |
Collapse
|
256
|
Chen Y, Ali M, Tayyab MB, Nazir MM, Umar M, Khan S, Ismail DM, Abdel-Maksoud MA, Ebaid H, Alamri A, Almutairi S, Almanaa TN, Kiani BH. The role of Prolyl 3-Hydroxylase 1 (P3H1) in tumor development and prognosis: a pan-cancer analysis with validation in colonic adenocarcinoma. Am J Transl Res 2025; 17:770-790. [PMID: 40092085 PMCID: PMC11909568 DOI: 10.62347/suvc1606] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2024] [Accepted: 12/16/2024] [Indexed: 03/19/2025]
Abstract
BACKGROUND Cancer is a multifaceted disease characterized by unregulated cell proliferation, evasion of apoptosis, and metastasis. Recent studies have highlighted the importance of extracellular matrix remodeling and post-translational modifications in tumorigenesis. Prolyl 3-hydroxylase 1 (P3H1), an enzyme involved in collagen hydroxylation, has gained attention for its role in cancer progression. METHODS This study investigates P3H1 expression, prognostic value, and functional relevance across multiple human cancers using a combination of bioinformatic and experimental approaches. RESULTS Using The Cancer Genome Atlas (TCGA) data from TIMER2.0 and UALCAN databases, we observed a significant upregulation of P3H1 mRNA and protein in various cancers. Prognostic analysis using GEPIA2 and KM plotter revealed that high P3H1 expression correlates with poorer overall survival in colon adenocarcinoma (COAD), kidney renal clear cell carcinoma (KIRC), and liver hepatocellular carcinoma (LIHC). Further, genetic and promoter methylation analyses showed low mutation frequencies and reduced methylation of P3H1 in specific cancer types. Functional and pathway enrichment analyses indicated that P3H1 is involved in collagen formation, endoplasmic reticulum activity, and pathways such as ECM-receptor interaction and PI3K-Akt signaling. Validation by enzyme linked immunosorbent assay in COAD patient serum samples demonstrated significantly elevated P3H1 levels compared to healthy controls, with an AUC approaching 1.0 by receiver operating characteristic (ROC) curve analysis. This suggests its potential as a diagnostic biomarker. Additionally, functional experiments were conducted in COAD cells to assess P3H1's role in tumorigenesis. Knockdown of P3H1 in HCT116 cells resulted in a significant reduction in cell proliferation, colony formation, and migratory abilities of these cells. CONCLUSION These findings emphasize P3H1's relevance in COAD, KIRC, and LIHC pathogenesis and possible utility in clinical diagnosis.
Collapse
Affiliation(s)
- Yanqin Chen
- Nanjing Drum Tower HospitalNanjing 210000, Jiangsu, China
| | - Moazzam Ali
- Department of Gastroenterology, Hayatabad Medical Complex PeshawarPeshawar 25120, Khyber Pakhtunkhwa, Pakistan
| | - Muhammad Bilal Tayyab
- Institute of Drug Discovery and Development, Zhengzhou UniversityZhengzhou 450001, Henan, China
| | | | - Muhammad Umar
- Department of Neurosurgery, Allied Hospital FaisalabadFaisalabad 37521, Punjab, Pakistan
| | - Salman Khan
- DHQ Teaching Hospital, GMCDikah, Abbottabad 22010, Khyber Pakhtunkhwa, Pakistan
| | | | - Mostafa A Abdel-Maksoud
- Department of Botany and Microbiology, College of Science, King Saud UniversityRiyadh 11451, Saudi Arabia
| | - Hossam Ebaid
- Department of Zoology, College of Science, King Saud UniversityP.O. Box 2455, Riyadh 11451, Saudi Arabia
| | - Abdulaziz Alamri
- Department of Biochemistry, College of Science, King Saud UniversityP.O. Box 2455, Riyadh 11451, Saudi Arabia
| | - Saeedah Almutairi
- Department of Botany and Microbiology, College of Science, King Saud UniversityRiyadh 11451, Saudi Arabia
| | - Taghreed N Almanaa
- Department of Botany and Microbiology, College of Science, King Saud UniversityRiyadh 11451, Saudi Arabia
| | - Bushra Hafeez Kiani
- Department of Biology and Biotechnology, Worcester Polytechnic InstituteWorcester, Massachuesetts 01609, USA
| |
Collapse
|
257
|
Nugraha HK, Hariharan AR, Huser AJ, Feldman DS. Diagnosis and Management of Orthopaedic Conditions Associated With Hereditary Sensory Autonomic Neuropathies. J Am Acad Orthop Surg 2025; 33:e205-e219. [PMID: 39602626 DOI: 10.5435/jaaos-d-24-00237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/28/2024] [Accepted: 09/19/2024] [Indexed: 11/29/2024] Open
Abstract
Hereditary sensory and autonomic neuropathies (HSANs) encompass a diverse group of inherited neuropathies characterized by notable sensory and autonomic involvement that affects musculoskeletal structures and systemic function. There are 8 recognized types of HSAN. The orthopaedic manifestations of HSAN are complex and diverse, including spinal deformity, Charcot arthropathy, osteomyelitis, fractures, osteonecrosis, osteoporosis, and skeletal deformities. The sensory neuropathy with involvement of small nerve fibers can lead to unnoticed burns, fractures, and joint trauma. Spinal involvement includes progressive scoliosis/kyphosis and acute neurologic compromise. Diagnosis is dependent on clinical suspicion and confirmed with genetic analysis. Treatment is focused on the eradication of infection, stabilization of fractures, and prevention of joint instability in the spine and extremities. This review focuses on the orthopaedic manifestations to aid healthcare professionals in the recognition and treatment of these conditions.
Collapse
Affiliation(s)
- Hans Kristian Nugraha
- From the Paley Orthopedic and Spine Institute, West Palm Beach, FL (Nugraha, Hariharan, Huser, and Feldman), and Department of Surgery, Florida Atlantic University School of Medicine (Hariharan and Feldman), Boca Raton, FL
| | | | | | | |
Collapse
|
258
|
Wang X, Ye H, Zhang S, Yang M, Wang X. Evaluation of the Performance of Three Large Language Models in Clinical Decision Support: A Comparative Study Based on Actual Cases. J Med Syst 2025; 49:23. [PMID: 39948214 DOI: 10.1007/s10916-025-02152-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2024] [Accepted: 01/23/2025] [Indexed: 05/09/2025]
Abstract
BACKGROUND Generative large language models (LLMs) are increasingly integrated into the medical field. However, their actual efficacy in clinical decision-making remains partially unexplored. This study aimed to assess the performance of the three LLMs, ChatGPT-4, Gemini, and Med-Go, in the domain of professional medicine when confronted with actual clinical cases. METHODS This study involved 134 clinical cases spanning nine medical disciplines. Each LLM was required to provide suggestions for diagnosis, diagnostic criteria, differential diagnosis, examination and treatment for every case. Responses were scored by two experts using a predefined rubric. RESULTS In overall performance among the models, Med-Go achieved the highest median score (37.5, IQR 31.9-41.5), while Gemini recorded the lowest (33.0, IQR 25.5-36.6), showing significant statistical difference among the three LLMs (p < 0.001). Analysis revealed that responses related to differential diagnosis were the weakest, while those pertaining to treatment recommendations were the strongest. Med-Go displayed notable performance advantages in gastroenterology, nephrology, and neurology. CONCLUSIONS The findings show that all three LLMs achieved over 60% of the maximum possible score, indicating their potential applicability in clinical practice. However, inaccuracies that could lead to adverse decisions underscore the need for caution in their application. Med-Go's superior performance highlights the benefits of incorporating specialized medical knowledge into LLMs training. It is anticipated that further development and refinement of medical LLMs will enhance their precision and safety in clinical use.
Collapse
Affiliation(s)
- Xueqi Wang
- Department of Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine, No.150, Jimo Road, Pudong New Area, Shanghai, China
| | - Haiyan Ye
- Department of Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine, No.150, Jimo Road, Pudong New Area, Shanghai, China
| | - Sumian Zhang
- Department of Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine, No.150, Jimo Road, Pudong New Area, Shanghai, China
| | - Mei Yang
- Department of Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine, No.150, Jimo Road, Pudong New Area, Shanghai, China
| | - Xuebin Wang
- Department of Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine, No.150, Jimo Road, Pudong New Area, Shanghai, China.
| |
Collapse
|
259
|
Violini A, Consoletti L, Finco G. Chronic Pain in Italy: Turning Numbers Into Actionable Solutions. Pain Res Manag 2025; 2025:3401242. [PMID: 39990863 PMCID: PMC11845262 DOI: 10.1155/prm/3401242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2024] [Accepted: 01/13/2025] [Indexed: 02/25/2025]
Abstract
Chronic pain (CP) is a condition that looms over the global social and health scenarios. After many years without having national data, an extensive overview of this disorder in Italy has been published in the first Rapporto Censis Grünenthal (Censis Grünenthal Pain Report). It confirms that 19.8% of the Italian adult population suffers from moderate or severe CP, and the vast majority of patients (86.2%) are not aware of the existence of pain management (PM) centers. Starting with the Rapporto Censis Grünenthal data analysis by the representatives of three Italian pain scientific societies, several unmet needs were highlighted for which affordable, innovative, and technological strategies were proposed. These solutions focused on interventions in three strategic areas: (1) information, education, and awareness about CP among patients and physicians; (2) organization of pain center networks to adequately cover the national territory, promoting a multimodal-interdisciplinary approach; and (3) use of currently available novel technologies to foster access to treatment. For this purpose, the authors suggested feasible solutions, such as promoting public educational campaigns to raise awareness of the existence of pain centers and the right to receive a proper PM, as indicated in Italy by the pioneering law 38/2010. Regarding organizational gaps, the authors highlighted the possibility of drawing on international models to improve pain centers with completely dedicated staff and community-based pain services while supporting the development of specialized procedural PM standards. Concerning technologies, investments in telehealth and digital tools would improve access to therapies throughout the territory, enabling efficient clinical assessment and helping deliver the most suitable treatments. Overall, greater awareness of the impact of CP and a better allocation of resources are needed to improve patient quality of life, thereby reducing costs for the healthcare system.
Collapse
Affiliation(s)
- Alessia Violini
- Department of Primary Care Director of Palliative Care and Hospice, ASL1 Imperia-Sanremo-Ventimiglia, Liguria, Italy
| | - Leonardo Consoletti
- Department of Medical and Surgical Sciences, Pain Medicine Unit, University Hospital of Foggia, Foggia, Italy
| | - Gabriele Finco
- Department of Medical Science and Public Health, University of Cagliari, Anesthesia and Intensive Care Therapy, Azienda Ospedaliero Universitaria Cagliari, Cagliari, Italy
| |
Collapse
|
260
|
Bonvin E, Perruchoud E, Tacchini-Jacquier N, Perrenoud J, Melly P, Celik S, Jean M, Verloo H. Models of Integrated Acute Care for Older Adult Inpatients That Incorporate Integrative Health: An Integrative Review. J Multidiscip Healthc 2025; 18:759-786. [PMID: 39963327 PMCID: PMC11831015 DOI: 10.2147/jmdh.s505404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2024] [Accepted: 01/29/2025] [Indexed: 02/20/2025] Open
Abstract
Background The use of integrated acute care for older adult inpatients is a growing field, especially the use of integrative health-care practices for managing complex, chronic, age-related health conditions. Scientific evidence suggests that these practices should be incorporated into older adult inpatients' daily care. Aim Conduct an integrative review of studies on integrated acute-care models for older adult inpatients that incorporate integrative health services. Methods We searched Medline Ovid ALL, Embase.com, CINAHL, APA PsycINFO Ovid, Web of Science Core Collection, ProQuest Dissertations & Theses A&I, Cochrane Library, and CAMBase bibliographic databases for studies, published between 1990 and 2023, on integrated acute-care models for older adult inpatients that incorporated integrative health services. The search associated the domains of acute care, geriatrics, internal medicine, rehabilitation, hospitalization, geriatric psychiatry, integrated/integrative care, care models, practices and coordination, interprofessionalism and multidisciplinarity, collaborative practices, and complementary therapies. The review was completed in June 2024. Results We retained 32 studies conducted in North America, Europe, Australia, and Asia, including 46,899 older adult inpatients, 39 physicians, 148 nurses, 695 allied health-care professionals, and 358 informal caregivers. Three integrated acute care models were identified: the Acute Care for Elders model, the Integrated General Hospital model, and the Transitional Care model. Three integrated acute psychogeriatric-care models were identified: the Admiral Nursing model, the Lewy body dementia Admiral nursing service model, and the Care for Acute Mentally Infirm Elders model. A single, hybrid, Integrated, People-Centred Health Services model for acute and community health care was identified. We found the Scaling Integrated Care in Context model for measuring integrated care development within health-care systems. Conclusion Few studies have investigated integrated acute-care models incorporating integrative health services for older adult inpatients. Existing acute-care models including integrative medicine should be explored further, and new, more inclusive models should be developed.
Collapse
Affiliation(s)
- Eric Bonvin
- Valais Hospital Directorate 1950 SION, Valais, Switzerland
| | - Elodie Perruchoud
- School of Health Sciences – Nursing Science (HES-SO – Valais) 1950 SION, Valais, Switzerland
| | | | - Jean Perrenoud
- Valais Hospital Directorate 1950 SION, Valais, Switzerland
| | - Pauline Melly
- School of Health Sciences – Nursing Science (HES-SO – Valais) 1950 SION, Valais, Switzerland
| | - Sacha Celik
- Old Age Psychiatry - Saint-Amé Clinic 1890 Saint-Maurice, Valais, Switzerland
| | - Michèle Jean
- Geriatrics - Saint-Amé Clinic 1890 Saint-Maurice, Valais, Switzerland
| | - Henk Verloo
- School of Health Sciences – Nursing Science (HES-SO – Valais) 1950 SION, Valais, Switzerland
| |
Collapse
|
261
|
Ji K, Wu Z, Han J, Zhai G, Liu J. Evaluating ChatGPT-4's performance on oral and maxillofacial queries: Chain of Thought and standard method. FRONTIERS IN ORAL HEALTH 2025; 6:1541976. [PMID: 40013098 PMCID: PMC11860867 DOI: 10.3389/froh.2025.1541976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2024] [Accepted: 01/28/2025] [Indexed: 02/28/2025] Open
Abstract
Objectives Oral and maxillofacial diseases affect approximately 3.5 billion people worldwide. With the continuous advancement of Artificial Intelligence technologies, particularly the application of generative pre-trained transformers like ChatGPT-4, there is potential to enhance public awareness of the prevention and early detection of these diseases. This study evaluated the performance of ChatGPT-4 in addressing oral and maxillofacial disease questions using standard approaches and the Chain of Thought (CoT) method, aiming to gain a deeper understanding of its capabilities, potential, and limitations. Materials and methods Three experts, drawing from their extensive experience and the most common questions in clinical settings, selected 130 open-ended questions and 1,805 multiple-choice questions from the national dental licensing examination. These questions encompass 12 areas of oral and maxillofacial surgery, including Prosthodontics, Pediatric Dentistry, Maxillofacial Tumors and Salivary Gland Diseases, and maxillofacial Infections. Results Using CoT approach, ChatGPT-4 exhibited marked enhancements in accuracy, structure, completeness, professionalism, and overall impression for open-ended questions, revealing statistically significant differences compared to its performance on general oral and maxillofacial inquiries. In the realm of multiple-choice questions, the application of CoT method boosted ChatGPT-4's accuracy across all major subjects, achieving an overall accuracy increase of 3.1%. Conclusions When employing ChatGPT-4 to address questions in oral and maxillofacial surgery, incorporating CoT as a querying method can enhance its performance and help the public improve their understanding and awareness of such issues. However, it is not advisable to consider it a substitute for doctors.
Collapse
Affiliation(s)
- Kaiyuan Ji
- School of Communication and Electronic Engineering, East China Normal University, Shanghai, China
| | - Zhihan Wu
- Department of Oral and Maxillofacial Head and Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Jing Han
- Department of Oral and Maxillofacial Head and Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Guangtao Zhai
- School of Communication and Electronic Engineering, East China Normal University, Shanghai, China
- School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai, China
| | - Jiannan Liu
- Department of Oral and Maxillofacial Head and Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| |
Collapse
|
262
|
Ostróżka-Cieślik A, Michalak M, Bryś T, Kudła M. The Potential of Hydrogel Preparations Containing Plant Materials in Supporting the Treatment of Vaginal and Vulvar Infections-Current State of Knowledge. Polymers (Basel) 2025; 17:470. [PMID: 40006132 PMCID: PMC11859247 DOI: 10.3390/polym17040470] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2025] [Revised: 01/24/2025] [Accepted: 01/31/2025] [Indexed: 02/27/2025] Open
Abstract
Vaginal hydrogels are a modern alternative to solid (tablets, globules) and other semi-solid forms of medication (ointments, creams) in the control of pathogenic microorganisms in diseases of the female reproductive tract. This review aims to summarize the current state of knowledge regarding the efficacy of hydrogels containing plant materials in the treatment of vaginal and vulvar infections. New therapies are essential to address the growing antimicrobial resistance crisis. Google Scholar, Web of Science, Cochrane, and Medline (PubMed) databases were searched. Twenty-five studies were included in the review, including basic, pre-clinical, and clinical studies. The results obtained confirmed the therapeutic potential of plant raw materials embedded in the polymer matrix of hydrogels. However, due to the small number of clinical trials conducted, further research in this area is needed.
Collapse
Affiliation(s)
- Aneta Ostróżka-Cieślik
- Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia,41-200 Sosnowiec, Poland
| | - Monika Michalak
- Department of Pharmaceutical Sciences, Medical College, Jan Kochanowski University, 25-317 Kielce, Poland;
| | - Tomasz Bryś
- Clinical Department of Perinatology and Oncological Gynaecology, Medical University of Silesia, 41-200 Sosnowiec, Poland; (T.B.); (M.K.)
| | - Marek Kudła
- Clinical Department of Perinatology and Oncological Gynaecology, Medical University of Silesia, 41-200 Sosnowiec, Poland; (T.B.); (M.K.)
| |
Collapse
|
263
|
Sismanoglu S, Capan BS. Performance of artificial intelligence on Turkish dental specialization exam: can ChatGPT-4.0 and gemini advanced achieve comparable results to humans? BMC MEDICAL EDUCATION 2025; 25:214. [PMID: 39930399 PMCID: PMC11809121 DOI: 10.1186/s12909-024-06389-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/04/2024] [Accepted: 11/21/2024] [Indexed: 02/14/2025]
Abstract
BACKGROUND AI-powered chatbots have spread to various fields including dental education and clinical assistance to treatment planning. The aim of this study is to assess and compare leading AI-powered chatbot performances in dental specialization exam (DUS) administered in Turkey and compare it with the best performer of that year. METHODS DUS questions for 2020 and 2021 were directed to ChatGPT-4.0 and Gemini Advanced individually. DUS questions were manually entered into AI-powered chatbot in their original form, in Turkish. The results obtained were compared with each other and the year's best performers. Candidates who score at least 45 points on this centralized exam are deemed to have passed and are eligible to select their preferred department and institution. The data was statistically analyzed using Pearson's chi-squared test (p < 0.05). RESULTS ChatGPT-4.0 received 83.3% correct response rate on the 2020 exam, while Gemini Advanced received 65% correct response rate. On the 2021 exam, ChatGPT-4.0 received 80.5% correct response rate, whereas Gemini Advanced received 60.2% correct response rate. ChatGPT-4.0 outperformed Gemini Advanced in both exams (p < 0.05). AI-powered chatbots performed worse in overall score (for 2020: ChatGPT-4.0, 65,5 and Gemini Advanced, 50.1; for 2021: ChatGPT-4.0, 65,6 and Gemini Advanced, 48.6) when compared to overall scores of the best performer of that year (68.5 points for year 2020 and 72.3 points for year 2021). This poor performance also includes the basic sciences and clinical sciences sections (p < 0.001). Additionally, periodontology was the clinical specialty in which both AI-powered chatbots achieved the best results, the lowest performance was determined in the endodontics and orthodontics. CONCLUSION AI-powered chatbots, namely ChatGPT-4.0 and Gemini Advanced, passed the DUS by exceeding the threshold score of 45. However, they still lagged behind the top performers of that year, particularly in basic sciences, clinical sciences, and overall score. Additionally, they exhibited lower performance in some clinical specialties such as endodontics and orthodontics.
Collapse
Affiliation(s)
- Soner Sismanoglu
- Faculty of Dentistry, Department of Restorative Dentistry, Istanbul University-Cerrahpasa, Istanbul, Turkey
| | - Belen Sirinoglu Capan
- Faculty of Dentistry, Department of Pediatric Dentistry, Istanbul University-Cerrahpasa, Istanbul, Turkey.
| |
Collapse
|
264
|
Miller M, DiCiurcio WT, Meade M, Buchan L, Gleimer J, Woods B, Kepler C. Appropriateness and Consistency of an Online Artificial Intelligence System's Response to Common Questions Regarding Cervical Fusion. Clin Spine Surg 2025:01933606-990000000-00435. [PMID: 39928039 DOI: 10.1097/bsd.0000000000001768] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/11/2024] [Accepted: 01/20/2025] [Indexed: 02/11/2025]
Abstract
STUDY DESIGN Prospective survey study. OBJECTIVE To address a gap that exists concerning ChatGPT's ability to respond to various types of questions regarding cervical surgery. SUMMARY OF BACKGROUND DATA Artificial Intelligence (AI) and machine learning have been creating great change in the landscape of scientific research. Chat Generative Pre-trained Transformer(ChatGPT), an online AI language model, has emerged as a powerful tool in clinical medicine and surgery. Previous studies have demonstrated appropriate and reliable responses from ChatGPT concerning patient questions regarding total joint arthroplasty, distal radius fractures, and lumbar laminectomy. However, there is a gap that exists in examining how accurate and reliable ChatGPT responses are to common questions related to cervical surgery. MATERIALS AND METHODS Twenty questions regarding cervical surgery were presented to the online ChatGPT-3.5 web application 3 separate times, creating 60 responses. Responses were then analyzed by 3 fellowship-trained spine surgeons across 2 institutions using a modified Global Quality Scale (1-5 rating) to evaluate accuracy and utility. Descriptive statistics were reported based on responses, and intraclass correlation coefficients were then calculated to assess the consistency of response quality. RESULTS Out of all questions proposed to the AI platform, the average score was 3.17 (95% CI, 2.92, 3.42), with 66.7% of responses being recorded to be of at least "moderate" quality by 1 reviewer. Nine (45%) questions yielded responses that were graded at least "moderate" quality by all 3 reviewers. The test-retest reliability was poor with the intraclass correlation coefficient (ICC) calculated as 0.0941 (-0.222, 0.135). CONCLUSION This study demonstrated that ChatGPT can answer common patient questions concerning cervical surgery with moderate quality during the majority of responses. Further research within AI is necessary to increase response.
Collapse
|
265
|
Cummings JAF, Dort J. A Descriptive Study Nursing Students' Knowledge and Attitudes Pediatric Pain: Where Are We Now? Pain Manag Nurs 2025:S1524-9042(25)00017-7. [PMID: 39934073 DOI: 10.1016/j.pmn.2025.01.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2024] [Revised: 01/11/2025] [Accepted: 01/18/2025] [Indexed: 02/13/2025]
Abstract
Pain management is an ethical responsibility of all professional nurses. Pain is a common symptom experienced in clients across the lifespan. PURPOSE The purpose of this study was to examine nursing students' knowledge and attitudes regarding pediatric pain management. DESIGN A retrospective descriptive design. METHODS Use of the Pediatric Nurses Knowledge and Attitudes Survey Regarding Pain Management (PNKAS Shriners Version 2002). The sample comprised of scores from 320 students enrolled in a pediatric course at a private school of nursing in the Northeastern United States. RESULTS Findings identified that the rate of correct answers ranged from 21.95% to 97.56%. Results showed a low level of student nurses' knowledge and attitudes regarding pediatric pain management. CONCLUSIONS The results highlight that regardless of the curricular changes that have been made, students continue to struggle with pediatric pain management with emphasis on pain management pharmacology. CLINICAL IMPLICATIONS Pediatric pain education needs to be improved in the undergraduate educational curricula. It is important for nursing schools to consider the possibility of integrating pain education in a systematic manner to better prepare students.
Collapse
Affiliation(s)
| | - JoChena Dort
- School of Nursing, Georgian Court University, Lakewood, NJ
| |
Collapse
|
266
|
Perogamvros L, Rochas V, Beau JB, Sterpenich V, Bayer L. The cathartic dream: Using a large language model to study a new type of functional dream in healthy and clinical populations. J Sleep Res 2025:e70001. [PMID: 39924340 DOI: 10.1111/jsr.70001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2024] [Revised: 01/12/2025] [Accepted: 01/28/2025] [Indexed: 02/11/2025]
Abstract
According to some theories of emotion regulation, dreams could modify negative emotions and ultimately reduce their intensity. We introduce here the idea of cathartic dream, a specific and separate type of emotional dream, which is characterized by a dynamic plot with emotional twists, and where negative emotions are expressed and ultimately decreased. This process would reflect psychological relief (catharsis according to the Aristotelian definition) and fulfil an emotion regulation function. We developed and validated a tool using a large language model to emotionally categorize the different dreams from dream diaries. Based on this tool, we were able to detect the prevalence of cathartic dreams in datasets of both healthy participants and patients with nightmares. Additionally, we observed the increase of cathartic dreams during 2 weeks of imagery rehearsal therapy and targeted memory reactivation during rapid eye movement sleep. We also demonstrate how the increase of cathartic dreams correlates significantly with the decrease of depression scores in patients with nightmares under therapy, thus supporting their likely functional role in well-being and their distinct nature among other emotional dreams.
Collapse
Affiliation(s)
- Lampros Perogamvros
- Center for Sleep Medicine, Department of Psychiatry, Geneva University Hospitals, Geneva, Switzerland
- Department of Basic Neurosciences, University of Geneva, Geneva, Switzerland
| | - Vincent Rochas
- M/EEG & Neuromod Platform, Fondation Campus Biotech Geneva, Geneva, Switzerland
| | | | - Virginie Sterpenich
- Department of Basic Neurosciences, University of Geneva, Geneva, Switzerland
| | - Laurence Bayer
- Center for Sleep Medicine, Department of Psychiatry, Geneva University Hospitals, Geneva, Switzerland
- Department of Basic Neurosciences, University of Geneva, Geneva, Switzerland
| |
Collapse
|
267
|
Tripathi D, Hajra K, Mulukutla A, Shreshtha R, Maity D. Artificial Intelligence in Biomedical Engineering and Its Influence on Healthcare Structure: Current and Future Prospects. Bioengineering (Basel) 2025; 12:163. [PMID: 40001682 PMCID: PMC11851410 DOI: 10.3390/bioengineering12020163] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2024] [Revised: 01/25/2025] [Accepted: 02/04/2025] [Indexed: 02/27/2025] Open
Abstract
Artificial intelligence (AI) is a growing area of computer science that combines technologies with data science to develop intelligent, highly computation-able systems. Its ability to automatically analyze and query huge sets of data has rendered it essential to many fields such as healthcare. This article introduces you to artificial intelligence, how it works, and what its central role in biomedical engineering is. It brings to light new developments in medical science, why it is being applied in biomedicine, key problems in computer vision and AI, medical applications, diagnostics, and live health monitoring. This paper starts with an introduction to artificial intelligence and its major subfields before moving into how AI is revolutionizing healthcare technology. There is a lot of emphasis on how it will transform biomedical engineering through the use of AI-based devices like biosensors. Not only can these machines detect abnormalities in a patient's physiology, but they also allow for chronic health tracking. Further, this review also provides an overview of the trends of AI-enabled healthcare technologies and concludes that the adoption of artificial intelligence in healthcare will be very high. The most promising are in diagnostics, with highly accurate, non-invasive diagnostics such as advanced imaging and vocal biomarker analyzers leading medicine into the future.
Collapse
Affiliation(s)
- Divya Tripathi
- School of Health Sciences, University of Petroleum and Energy Studies, Dehradun 248007, Uttarakhand, India; (D.T.)
| | - Kasturee Hajra
- School of Public Health, SRM Medical College, Chennai 603203, Tamil Nadu, India
| | - Aditya Mulukutla
- School of Health Sciences, University of Petroleum and Energy Studies, Dehradun 248007, Uttarakhand, India; (D.T.)
| | - Romi Shreshtha
- School of Health Sciences, University of Petroleum and Energy Studies, Dehradun 248007, Uttarakhand, India; (D.T.)
| | - Dipak Maity
- Integrated Nanosystems Development Institute, Indiana University Indianapolis, Indianapolis, IN 46202, USA
- Department of Chemistry and Chemical Biology, Indiana University Indianapolis, Indianapolis, IN 46202, USA
| |
Collapse
|
268
|
Singaravelan N, Tollefsbol TO. Polyphenol-Based Prevention and Treatment of Cancer Through Epigenetic and Combinatorial Mechanisms. Nutrients 2025; 17:616. [PMID: 40004944 PMCID: PMC11858336 DOI: 10.3390/nu17040616] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2025] [Revised: 01/29/2025] [Accepted: 02/06/2025] [Indexed: 02/27/2025] Open
Abstract
Polyphenols have been shown to be utilized as an effective treatment for cancer by acting as a DNMT or HDAC inhibitor, reducing inflammatory processes, and causing cell cycle arrest. While there have been many studies demonstrating the anti-cancerous potential of individual polyphenols, there are limited studies on the combinatorial effects of polyphenols. This review focuses on how combinations of different polyphenols can be used as a chemotherapeutic treatment option for patients. Specifically, we examine the combinatorial effects of three commonly used polyphenols: curcumin, resveratrol, and epigallocatechin gallate. These combinations have been shown to induce apoptosis, prevent colony formation and migration, increase tumor suppression, reduce cell viability and angiogenesis, and create several epigenetic modifications. In addition, these anti-cancerous effects were synergistic and additive. Thus, these findings suggest that using different combinations of polyphenols at the appropriate concentrations can be used as a better and more efficacious treatment against cancer as compared to using polyphenols individually.
Collapse
Affiliation(s)
- Neha Singaravelan
- Department of Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA;
| | - Trygve O. Tollefsbol
- Integrative Center for Aging Research, University of Alabama at Birmingham, Birmingham, AL 35294, USA
- O’Neal Comprehensive Cancer Research, University of Alabama at Birmingham, Birmingham, AL 35294, USA
- Nutrition Obesity Research Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA
- Comprehensive Diabetes Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA
| |
Collapse
|
269
|
Huang Q, Chen Y, Sun X, Su Y, Zhou R, Chen G, Zhu T. Hydromorphone reduced the incidence of emergence agitation after adenotonsillectomy in children with obstructive sleep apnea: A randomized, double-blind study. Open Med (Wars) 2025; 20:20241129. [PMID: 39927161 PMCID: PMC11806236 DOI: 10.1515/med-2024-1129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2024] [Revised: 11/28/2024] [Accepted: 12/09/2024] [Indexed: 02/11/2025] Open
Abstract
Purpose Emergence agitation (EA) after (adeno)tonsillectomy (AT) surgery impairs recovery in children. Adequate analgesia plays a crucial role in reducing EA incidence. This study investigated whether hydromorphone infusion (30 μg/kg) during anesthesia induction could reduce EA following AT surgery for obstructive sleep apnea in children. Patients and methods A total of 186 ASA I-III children aged 3-7 years undergoing AT surgery were enrolled in a blinded randomized trial comparing hydromorphone (30 μg/kg) to fentanyl (4 μg/kg). The primary outcome was EA incidence within 30 min post-extubation. Secondary outcomes included pediatric anesthesia emergence delirium (PAED), face, legs, activity, crying, consolability (FLACC), Ramsay sedation scores, extubation time, rescue analgesia incidence, and adverse events. Results The incidence of EA was significantly lower in the hydromorphone group [48.4% (45/93) vs 64.5% (60/93); absolute difference: 16.1%; 95% CI: 18.9-29.5%; P = 0.027]. Hydromorphone improved PAED, FLACC, and Ramsay scores and reduced moderate-to-severe pain and rescue analgesia. No postoperative complications occurred in either group. Conclusion Hydromorphone at 30 μg/kg effectively reduces the incidence of EA within 30 min post-extubation in children after AT surgery compared to fentanyl. It shows superior analgesia and has a low incidence of adverse effects.
Collapse
Affiliation(s)
- Qiyuan Huang
- Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China
| | - Yang Chen
- Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China
| | - Xiaohui Sun
- Department of Anesthesiology and Operation Center, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, Sichuan, China
| | - Yongwei Su
- Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China
| | - Ruihao Zhou
- Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China
| | - Guo Chen
- Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China
| | - Tao Zhu
- Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China
| |
Collapse
|
270
|
Yang M, Guo J, Li J, Wang S, Sun Y, Liu Y, Peng Y. Platycodon grandiflorum-derived extracellular vesicles suppress triple-negative breast cancer growth by reversing the immunosuppressive tumor microenvironment and modulating the gut microbiota. J Nanobiotechnology 2025; 23:92. [PMID: 39920791 PMCID: PMC11804104 DOI: 10.1186/s12951-025-03139-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2024] [Accepted: 01/19/2025] [Indexed: 02/09/2025] Open
Abstract
Despite the approval of several artificial nanotherapeutics for the treatment of triple-negative breast cancer (TNBC), significant challenges, including unsatisfactory therapeutic outcomes, severe side effects, and the high cost of large-scale production, still restrict their long-term application. In contrast, plant-derived extracellular vesicles (PEVs) exhibit promising potential in cancer therapy due to their negligible systemic toxicity, high bioavailability and cost- effectiveness. In this study, we developed an alternative strategy to inhibit TNBC via Platycodon grandiflorum (PG)-derived extracellular vesicles (PGEVs). The PGEVs were isolated by ultracentrifugation and sucrose gradient centrifugation method and contained adequate functional components such as proteins, lipids, RNAs and active molecules. PGEVs exhibited remarkable stability, tolerating acidic digestion and undergoing minimal changes in simulated gastrointestinal fluid. They were efficiently taken up by tumor cells and induced increased production of reactive oxygen species (ROS), leading to tumor cell proliferation inhibition and apoptosis, particularly in the TNBC cell line 4T1. Additionally, PGEVs facilitated the polarization of tumor-associated macrophages (TAMs) toward M1 phenotype and increased the secretion of pro-inflammatory cytokines. Further in vivo investigations revealed that PGEVs efficiently accumulated in 4T1 tumors and exerted significant therapeutic effects through boosting systemic anti-tumor immune responses and modulating the gut microbiota whether administered orally or intravenously (i.v.). In conclusion, these findings highlight PGEVs as a promising natural, biocompatible and efficient nanotherapeutic candidate for treating TNBC.
Collapse
Affiliation(s)
- Min Yang
- Institute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Changchun, 130112, China
| | - Jia Guo
- Institute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Changchun, 130112, China
| | - Jinxian Li
- Institute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Changchun, 130112, China
| | - Shuyue Wang
- School of Chemistry and Life Science, Changchun University of Technology, Changchun, 130012, China
| | - Yuan Sun
- Institute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Changchun, 130112, China
| | - Ying Liu
- Institute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Changchun, 130112, China
| | - Yinghua Peng
- Institute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Changchun, 130112, China.
| |
Collapse
|
271
|
Shin DA, Chang MC. Consciousness Research Through Pain. Healthcare (Basel) 2025; 13:332. [PMID: 39942521 PMCID: PMC11816597 DOI: 10.3390/healthcare13030332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2024] [Revised: 01/24/2025] [Accepted: 02/05/2025] [Indexed: 02/16/2025] Open
Abstract
Background/Objectives: Consciousness is a complex and elusive phenomenon encompassing self-awareness, sensory perception, emotions, and cognition. Despite significant advances in neuroscience, understanding the neural mechanisms underlying consciousness remains challenging. Pain, as a subjective and multifaceted experience, offers a unique lens for exploring consciousness by integrating sensory inputs with emotional and cognitive dimensions. This study examines the relationship between consciousness and pain, highlighting the potential of pain as a model for understanding the interplay between subjective experience and neural activity. Methods: Literature review. Results: Key theories of consciousness, such as the Global Workspace Theory and the Integrated Information Theory, provide diverse frameworks for interpreting the emergence of consciousness. Similarly, pain research emphasizes the role of subjective interpretation and emotional context in shaping sensory experiences, reflecting broader challenges in consciousness studies. The limitations of current methodologies, particularly the difficulty of objectively measuring subjective phenomena, like pain and consciousness, are also addressed. This highlights the importance of neural correlates, with a particular focus on brain regions, such as the anterior cingulate cortex and the insula, which bridge sensory and emotional experiences. By analyzing the shared attributes of pain and consciousness, this study underscores the potential for pain to serve as a measurable proxy in consciousness research. Conclusions: Ultimately, it contributes to unraveling the neural and philosophical underpinnings of consciousness, offering implications for mental health treatment and advancements in artificial intelligence. This study fills a critical gap by leveraging pain as a measurable and reproducible model for exploring the neural and subjective mechanisms of consciousness. By combining theoretical frameworks with empirical evidence, it offers novel insights into how consciousness emerges from neural processes.
Collapse
Affiliation(s)
- Dong Ah Shin
- Department of Neurosurgery, Spine and Spinal Cord Institute, Severance Hospital, Yonsei University College of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea;
| | - Min Cheol Chang
- Department of Physical Medicine and Rehabilitation, College of Medicine, Yeungnam University, 170 Hyeonchung-ro, Nam-gu, Daegu 42415, Republic of Korea
| |
Collapse
|
272
|
Yang Y, Li W, Zhao Y, Sun M, Xing F, Yang J, Zhou Y. GRP78 in Glioma Progression and Therapy: Implications for Targeted Approaches. Biomedicines 2025; 13:382. [PMID: 40002794 PMCID: PMC11852679 DOI: 10.3390/biomedicines13020382] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2024] [Revised: 01/24/2025] [Accepted: 02/03/2025] [Indexed: 02/27/2025] Open
Abstract
Glioma is the most common primary malignant brain tumor, accounting for the majority of brain cancer-related deaths. Considering the limited efficacy of conventional therapies, novel molecular targeted therapies have been developed to improve outcomes and minimize toxicity. Glucose-regulated protein 78 (GRP78), a molecular chaperone primarily localized in the endoplasmic reticulum (ER), has received increasing attention for its role in glioma progression and resistance to conventional therapies. Overexpressed in gliomas, GRP78 supports tumor growth, survival, and therapeutic resistance by maintaining cellular homeostasis and regulating multiple signaling pathways. Its aberrant expression correlates with higher tumor grades and poorer patient prognosis. Beyond its intracellular functions, GRP78's presence on the cell surface and its role in the tumor microenvironment underscore its potential as a therapeutic target. Recent studies have explored innovative strategies to target GRP78, including small molecule inhibitors, monoclonal antibodies, and chimeric antigen receptor (CAR) T cell therapy, showing significant potential in glioma treatment. This review explores the biological characteristics of GRP78, its role in glioma pathophysiology, and the potential of GRP78-targeted therapy as a novel strategy to overcome treatment resistance and improve clinical outcomes. GRP78-targeted therapy, either alone or in combination with conventional treatments, could be a novel and attractive strategy for future glioma treatment.
Collapse
Affiliation(s)
- Yue Yang
- Department of Chemistry, College of Sciences, Shanghai University, Shanghai 200444, China
| | - Wen Li
- School of Biomedical Engineering (Suzhou), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China; (W.L.); (Y.Z.)
- Department of Biomaterials and Stem Cells, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China
| | - Yu Zhao
- School of Biomedical Engineering (Suzhou), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China; (W.L.); (Y.Z.)
- Department of Biomaterials and Stem Cells, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China
| | - Minxuan Sun
- School of Biomedical Engineering (Suzhou), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China; (W.L.); (Y.Z.)
- Department of Biomaterials and Stem Cells, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China
| | - Feifei Xing
- Department of Chemistry, College of Sciences, Shanghai University, Shanghai 200444, China
| | - Jiao Yang
- Suzhou Research Center of Medical School, Institute of Clinical Medicine Research, Suzhou Hospital, The Affiliated Hospital of Medical School, Nanjing University, Lijiang Road No. 1, Suzhou 215153, China
- Jiangsu Province Engineering Research Center of Molecular Target Therapy and Companion Diagnostics in Oncology, Suzhou Vocational Health College, Suzhou 215009, China
| | - Yuanshuai Zhou
- School of Biomedical Engineering (Suzhou), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China; (W.L.); (Y.Z.)
- Department of Biomaterials and Stem Cells, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China
| |
Collapse
|
273
|
Xu L, Xu P, Wang J, Ji H, Zhang L, Tang Z. Advancements in clinical research and emerging therapies for triple-negative breast cancer treatment. Eur J Pharmacol 2025; 988:177202. [PMID: 39675457 DOI: 10.1016/j.ejphar.2024.177202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2024] [Revised: 11/30/2024] [Accepted: 12/09/2024] [Indexed: 12/17/2024]
Abstract
Triple-negative breast cancer (TNBC), defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2) expression, is acknowledged as the most aggressive form of breast cancer (BC), comprising 15%-20% of all primary cases. Despite the prevalence of TNBC, effective and well-tolerated targeted therapies remain limited, with chemotherapy continuing to be the mainstay of treatment. However, the horizon is brightened by recent advancements in immunotherapy and antibody-drug conjugates (ADCs), which have garnered the U.S. Food and Drug Administration (FDA) approval for various stages of TNBC. Poly (ADP-ribose) polymerase inhibitors (PARPi), particularly for TNBC with BRCA mutations, present a promising avenue, albeit with the challenge of resistance that must be addressed. The success of phosphoinositide-3 kinase (PI3K) pathway inhibitors in hormone receptor (HR)-positive BC suggests potential applicability in TNBC, spurring optimism within the research community. This review endeavors to offer a comprehensive synthesis of both established and cutting-edge targeted therapies for TNBC. We delve into the specifics of PARPi, androgen receptor (AR) inhibitors, Cancer stem cells (CSCs), PI3K/Protein Kinase B (AKT)/mammalian target of rapamycin (mTOR), the transforming growth factor-beta (TGF-β), Ntoch, Wnt/β-catenin, hedgehog (Hh) pathway inhibitors, Epigenetic target-mediated drug delivery, ADCs, immune checkpoint inhibitors (ICIs)and novel immunotherapeutic solutions, contextualizing TNBC within current treatment paradigms. By elucidating the mechanisms of these drugs and their prospective clinical applications, we aim to shed light on the challenges and underscore the beacon of hope that translational research and innovative therapies represent for the oncology field.
Collapse
Affiliation(s)
- Lili Xu
- Department of Pharmacy, Shaoxing People's Hospital, Shaoxing, Zhejiang, 312000, China
| | - Pengtao Xu
- Department of Pharmacy, Shaoxing People's Hospital, Shaoxing, Zhejiang, 312000, China
| | - Jingsong Wang
- Department of Pharmacy, Guangyuan Central Hospital, Guangyuan, Sichuan, 628000, China
| | - Hui Ji
- Department of Pharmacy, Shaoxing People's Hospital, Shaoxing, Zhejiang, 312000, China
| | - Lin Zhang
- Department of Pharmacy, Shaoxing People's Hospital, Shaoxing, Zhejiang, 312000, China
| | - Zhihua Tang
- Department of Pharmacy, Shaoxing People's Hospital, Shaoxing, Zhejiang, 312000, China.
| |
Collapse
|
274
|
Maurice-Szamburski A, Quemeneur C, Rozier R, Cuvillon P, Ecoffey C. Intravenously Administered Nonsteroidal Anti-Inflammatory Drugs in Clinical Practice: A Narrative Review. PHARMACY 2025; 13:18. [PMID: 39998016 PMCID: PMC11859530 DOI: 10.3390/pharmacy13010018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2024] [Revised: 01/22/2025] [Accepted: 02/03/2025] [Indexed: 02/26/2025] Open
Abstract
Intravenously administered nonsteroidal anti-inflammatory drugs (NSAIDs) constitute a crucial component of multimodal analgesia strategies in surgical settings. This narrative review aims to provide an up-to-date evaluation of the efficacy, safety, and clinical use of intravenous (IV) NSAIDs for perioperative pain management in adults and children. The NSAIDs and selective COX-2 inhibitors (coxibs) approved in Europe for the short-term symptomatic treatment of acute, moderate perioperative pain via IV infusion in adults and/or children have been influenced by US and global guidelines and practice: the drugs primarily reviewed here are ibuprofen, ketorolac, ketoprofen, naproxen, paracetamol, and acetylsalicylic acid. Furthermore, intravenous ibuprofen is authorized for the short-term symptomatic treatment of fever. In contrast to intravenous ketoprofen, intravenous ibuprofen is authorized for administration to children over 6 years of age or weighing more than 20 kg. Overall, IV ibuprofen had a more favorable profile with regard to peri- and postoperative opioid sparing and pain relief. Oral ibuprofen and IV ibuprofen have similar levels of efficacy, although IV ibuprofen has a shorter onset of action and is required in patients who are unable to take oral medications. The frequency of significant adverse events appears to be similar for ibuprofen and paracetamol. Systematic reviews and meta-analyses report that intravenous NSAIDs reduce postoperative opioid consumption by approximately 20-60%, improving pain management with fewer opioid-related side effects. In indications in infants, the choice of medication is limited, and the oral route is not always feasible; IV formulations of ibuprofen are preferred in this setting. Topics for further research should include head-to-head trials of IV NSAIDs.
Collapse
Affiliation(s)
- Axel Maurice-Szamburski
- Department of Anesthesiology and Critical Care, Pasteur University Hospital, 06300 Nice, France
| | - Cyril Quemeneur
- Clinique Drouot Sport, 75009 Paris, France
- Anesthesia and Intensive Care Department, Raymond Poincaré Hospital, APHP, 92380 Garches, France
| | - Romain Rozier
- Department of Anesthesiology and Critical Care, L’Archet University Hospital, 06200 Nice, France
| | - Philippe Cuvillon
- Department of Anesthesiology, Intensive Care and Perioperative Medicine, Clinical Epidemiology, Public Health, and Innovation in Methodology, CHU Nimes, University Montpellier, 30908 Nimes, France
| | - Claude Ecoffey
- Department d’Anesthésie Réanimation and Médecine Péri Opératoire, Hôpital Pontchaillou, Université Rennes, 35000 Rennes, France
| |
Collapse
|
275
|
Xu J, Li Y, Feng Z, Chen H. Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy. Cells 2025; 14:221. [PMID: 39937012 PMCID: PMC11816580 DOI: 10.3390/cells14030221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2024] [Revised: 01/22/2025] [Accepted: 01/31/2025] [Indexed: 02/13/2025] Open
Abstract
Cigarette smoke (CS), an intricate blend comprising over 4000 compounds, induces abnormal cellular reactions that harm multiple tissues. Non-alcoholic fatty liver disease (NAFLD) is a prevalent chronic liver disease (CLD), encompassing non-alcoholic fatty liver (NAFL), non-alcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma (HCC). Recently, the term NAFLD has been changed to metabolic dysfunction-associated steatotic liver disease (MASLD), and NASH has been renamed metabolic dysfunction-associated steatohepatitis (MASH). A multitude of experiments have confirmed the association between CS and the incidence and progression of MASLD. However, the specific signaling pathways involved need to be updated with new scientific discoveries. CS exposure can disrupt lipid metabolism, induce inflammation and apoptosis, and stimulate liver fibrosis through multiple signaling pathways that promote the progression of MASLD. Currently, there is no officially approved efficacious pharmaceutical intervention in clinical practice. Therefore, lifestyle modifications have emerged as the primary therapeutic approach for managing MASLD. Smoking cessation and the application of a series of natural ingredients have been shown to ameliorate pathological changes in the liver induced by CS, potentially serving as an effective approach to decelerating MASLD development. This article aims to elucidate the specific signaling pathways through which smoking promotes MASLD, while summarizing the reversal factors identified in recent studies, thereby offering novel insights for future research on and the treatment of MASLD.
Collapse
Affiliation(s)
- Jiatong Xu
- Queen Mary School, Medical College, Nanchang University, Nanchang 330006, China; (J.X.); (Y.L.); (Z.F.)
| | - Yifan Li
- Queen Mary School, Medical College, Nanchang University, Nanchang 330006, China; (J.X.); (Y.L.); (Z.F.)
| | - Zixuan Feng
- Queen Mary School, Medical College, Nanchang University, Nanchang 330006, China; (J.X.); (Y.L.); (Z.F.)
| | - Hongping Chen
- Department of Histology and Embryology, Jiangxi Medical College, Nanchang University, Nanchang 330019, China
| |
Collapse
|
276
|
Suminaga K, Nomizo T, Yoshida H, Ozasa H. The impact of PD-L1 polymorphisms on the efficacy of immune checkpoint inhibitors depends on the tumor proportion score: a retrospective study. J Cancer Res Clin Oncol 2025; 151:61. [PMID: 39903279 PMCID: PMC11794342 DOI: 10.1007/s00432-024-06081-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2024] [Accepted: 12/31/2024] [Indexed: 02/06/2025]
Abstract
PURPOSE This study aims to clarify the relationship between rs2282055, a single-nucleotide polymorphism (SNP) in programmed death-ligand 1 (PD-L1), and TPS. Polcaro et al. (2024) showed that rs822336, a SNP in PD-L1, predicts the effect of immune checkpoint inhibitors (ICIs). However, the study did not show a relationship between rs822336 and the tumor proportion score (TPS), which is currently used as a primary marker. Therefore, we examined this relationship. METHOD Patients treated with immune checkpoint inhibitor monotherapy for non-small cell lung cancer at Kyoto University Hospital until January 2023, with TPS data and biological specimens available for SNP measurement, were eligible for this study. Genomic DNA was extracted from peripheral blood leukocytes. We used rs2282055, which is in linkage disequilibrium with rs822336, instead of rs822336, because of its distribution in the Asian patient population. We retrospectively extracted data on age, sex, smoking history, driver mutations, TPS, progression-free survival (PFS), and best response to ICI from medical records. RESULT The rs2282055 T/T genotype was associated with significantly better PFS in the TPS-negative population than in the other genotypes. In contrast, no differences were observed in TPS-positive patients. CONCLUSION The rs2282055 genotype may help in selecting cases from the TPS-negative patient population that may benefit from ICI therapy.
Collapse
Affiliation(s)
- Keiichiro Suminaga
- Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-Ku, Kyoto, 606-8507, Japan
| | - Takashi Nomizo
- Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-Ku, Kyoto, 606-8507, Japan.
| | - Hironori Yoshida
- Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-Ku, Kyoto, 606-8507, Japan
| | - Hiroaki Ozasa
- Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-Ku, Kyoto, 606-8507, Japan
| |
Collapse
|
277
|
Sahafi P, Sadeghi R, Askari E, Sahebkari A, Ghahraman M, Khadivi E, Khazaeni K, Dabbagh Kakhki VR, Harsini S. Sentinel Node Biopsy in Laryngeal Cancer: A Systematic Review and Meta-Analysis. Diagnostics (Basel) 2025; 15:366. [PMID: 39941296 PMCID: PMC11817158 DOI: 10.3390/diagnostics15030366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2024] [Revised: 01/24/2025] [Accepted: 01/27/2025] [Indexed: 02/16/2025] Open
Abstract
Background: Sentinel lymph node (SLN) biopsy offers a minimally invasive approach to staging lymph node involvement in laryngeal squamous cell carcinoma (SCC). Despite its adoption in other cancers, its accuracy in laryngeal SCC remains under investigation. This systematic review and meta-analysis evaluates the diagnostic performance of SLN mapping in laryngeal cancer. Methods: A systematic search of MEDLINE, Scopus, and Google Scholar was conducted using the keywords "(larynx OR laryngeal) AND sentinel", with no date or language restrictions. Studies reporting SLN detection rates and/or sensitivity in laryngeal SCC were included. A random-effects model was applied for data pooling, and subgroup analyses were performed based on tumor location (supraglottic versus transglottic) and mapping material (radiotracer versus blue dye). Publication bias was assessed using funnel plots and statistical methods. Results: Nineteen studies, encompassing 366 patients, were analyzed. The overall pooled SLN detection rate was 90.8% (95% CI: 86-94.1), and sensitivity was 88% (95% CI: 81-94). Supraglottic tumors demonstrated superior outcomes (detection rate: 93.7%, sensitivity: 96%) compared to transglottic tumors (detection rate: 84.7%, sensitivity: 71%). Radiotracers significantly outperformed blue dye, with detection rates of 90.8% versus 81.5% and sensitivities of 88% versus 77%. Conclusions: SLN mapping is a reliable technique for staging laryngeal SCC, particularly for supraglottic tumors, where high detection rates and sensitivity were observed. Radiotracers offer superior performance compared to blue dye, underscoring their clinical value. These findings support the feasibility and accuracy of SLN biopsy in laryngeal cancer, while emphasizing the importance of tumor location and mapping material.
Collapse
Affiliation(s)
- Pegah Sahafi
- Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad 9176699199, Iran; (P.S.); (R.S.); (E.A.); (A.S.); (M.G.); (V.R.D.K.)
| | - Ramin Sadeghi
- Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad 9176699199, Iran; (P.S.); (R.S.); (E.A.); (A.S.); (M.G.); (V.R.D.K.)
| | - Emran Askari
- Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad 9176699199, Iran; (P.S.); (R.S.); (E.A.); (A.S.); (M.G.); (V.R.D.K.)
| | - Azadeh Sahebkari
- Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad 9176699199, Iran; (P.S.); (R.S.); (E.A.); (A.S.); (M.G.); (V.R.D.K.)
| | - Mitra Ghahraman
- Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad 9176699199, Iran; (P.S.); (R.S.); (E.A.); (A.S.); (M.G.); (V.R.D.K.)
| | - Ehsan Khadivi
- Sinus and Surgical Endoscopic Research Center, Mashhad University of Medical Sciences, Mashhad 9176699199, Iran; (E.K.); (K.K.)
| | - Kamran Khazaeni
- Sinus and Surgical Endoscopic Research Center, Mashhad University of Medical Sciences, Mashhad 9176699199, Iran; (E.K.); (K.K.)
| | - Vahid Reza Dabbagh Kakhki
- Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad 9176699199, Iran; (P.S.); (R.S.); (E.A.); (A.S.); (M.G.); (V.R.D.K.)
| | - Sara Harsini
- Department of Molecular Imaging and Therapy, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada
| |
Collapse
|
278
|
Genes N, Sills J, Heaton HA, Shy BD, Scofi J. Addressing Note Bloat: Solutions for Effective Clinical Documentation. J Am Coll Emerg Physicians Open 2025; 6:100031. [PMID: 40012671 PMCID: PMC11852943 DOI: 10.1016/j.acepjo.2024.100031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2024] [Revised: 11/15/2024] [Accepted: 11/25/2024] [Indexed: 02/28/2025] Open
Abstract
Clinical documentation in the United States has grown longer and more difficult to read, a phenomenon described as "note bloat." This issue is especially pronounced in emergency medicine, where high diagnostic uncertainty and brief evaluations demand focused, efficient chart review to inform decision-making. Note bloat arises from multiple factors: efforts to enhance billing, mitigate malpractice risk, and leverage electronic health record tools that improve speed and completeness. We discuss best practices based on available evidence and expert opinion to improve note clarity and concision. Recent E/M coding reforms aim to streamline documentation by prioritizing medical decision-making over details of historical and physical examination, though implementation varies. New technologies such as generative artificial intelligence present opportunities and challenges for documentation practices. Addressing note bloat will require ongoing effort from clinical leadership, electronic health record vendors, and professional organizations.
Collapse
Affiliation(s)
- Nicholas Genes
- Department of Emergency Medicine Ronald O. Perelman, NYU Grossman School of Medicine, New York, New York, USA
| | - Joseph Sills
- UMass Chan Medical School – Baystate, Springfield, Massachusetts, USA
| | | | - Bradley D. Shy
- University of Colorado School of Medicine, Aurora, Colorado, USA
| | - Jean Scofi
- Emergency Medicine Service Line, Northwell Health, New Hyde Park, New York, USA
| |
Collapse
|
279
|
Van den Bossche V, Vignau J, Vigneron E, Rizzi I, Zaryouh H, Wouters A, Ambroise J, Van Laere S, Beyaert S, Helaers R, van Marcke C, Mignion L, Lepicard EY, Jordan BF, Guilbaud C, Lowyck O, Dahou H, Mendola A, Desgres M, Aubert L, Gerin I, Bommer GT, Boidot R, Vermonden P, Warnant A, Larondelle Y, Machiels JP, Feron O, Schmitz S, Corbet C. PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma. Nat Commun 2025; 16:1237. [PMID: 39890801 PMCID: PMC11785796 DOI: 10.1038/s41467-025-56675-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2023] [Accepted: 01/24/2025] [Indexed: 02/03/2025] Open
Abstract
Anti-epidermal growth factor receptor (EGFR) therapy (cetuximab) shows a limited clinical benefit for patients with locally advanced or recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), due to the frequent occurrence of secondary resistance mechanisms. Here we report that cetuximab-resistant HNSCC cells display a peroxisome proliferator-activated receptor alpha (PPARα)-mediated lipid metabolism reprogramming, with increased fatty acid uptake and oxidation capacities, while glycolysis is not modified. This metabolic shift makes cetuximab-resistant HNSCC cells particularly sensitive to a pharmacological inhibition of either carnitine palmitoyltransferase 1A (CPT1A) or PPARα in 3D spheroids and tumor xenografts in mice. Importantly, the PPARα-related gene signature, in human clinical datasets, correlates with lower response to anti-EGFR therapy and poor survival in HNSCC patients, thereby validating its clinical relevance. This study points out lipid metabolism rewiring as a non-genetic resistance-causing mechanism in HNSCC that may be therapeutically targeted to overcome acquired resistance to anti-EGFR therapy.
Collapse
Affiliation(s)
- Valentin Van den Bossche
- Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B1.57.04, B-1200, Brussels, Belgium
- King Albert II Cancer Institute, Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, B-1200, Brussels, Belgium
| | - Julie Vignau
- Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B1.57.04, B-1200, Brussels, Belgium
| | - Engy Vigneron
- Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B1.57.04, B-1200, Brussels, Belgium
| | - Isabella Rizzi
- Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B1.57.04, B-1200, Brussels, Belgium
| | - Hannah Zaryouh
- Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, B-2610, Antwerp, Belgium
| | - An Wouters
- Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, B-2610, Antwerp, Belgium
| | - Jérôme Ambroise
- Centre des Technologies Moléculaires Appliquées (CTMA), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 54, B-1200, Brussels, Belgium
| | - Steven Van Laere
- Translational Cancer Research Unit (TCRU), GZA Ziekenhuizen, Antwerp, Belgium
| | - Simon Beyaert
- King Albert II Cancer Institute, Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, B-1200, Brussels, Belgium
- Pole of Molecular Imaging, Radiotherapy and Oncology (MIRO), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B-1200, Brussels, Belgium
- Department of Head and Neck Surgery, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, B-1200, Brussels, Belgium
| | - Raphaël Helaers
- Laboratory of Human Molecular Genetics, de Duve Institute, UCLouvain, B-1200, Brussels, Belgium
| | - Cédric van Marcke
- King Albert II Cancer Institute, Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, B-1200, Brussels, Belgium
- Pole of Molecular Imaging, Radiotherapy and Oncology (MIRO), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B-1200, Brussels, Belgium
| | - Lionel Mignion
- Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, UCLouvain, B-1200, Brussels, Belgium
| | - Elise Y Lepicard
- Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, UCLouvain, B-1200, Brussels, Belgium
| | - Bénédicte F Jordan
- Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, UCLouvain, B-1200, Brussels, Belgium
| | - Céline Guilbaud
- Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B1.57.04, B-1200, Brussels, Belgium
| | - Olivier Lowyck
- King Albert II Cancer Institute, Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, B-1200, Brussels, Belgium
- Pole of Molecular Imaging, Radiotherapy and Oncology (MIRO), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B-1200, Brussels, Belgium
| | - Hajar Dahou
- Pole of Molecular Imaging, Radiotherapy and Oncology (MIRO), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B-1200, Brussels, Belgium
| | - Antonella Mendola
- Pole of Molecular Imaging, Radiotherapy and Oncology (MIRO), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B-1200, Brussels, Belgium
| | - Manon Desgres
- Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B1.57.04, B-1200, Brussels, Belgium
| | - Léo Aubert
- Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B1.57.04, B-1200, Brussels, Belgium
| | - Isabelle Gerin
- Metabolic Research Group, de Duve Institute, UCLouvain, B-1200, Brussels, Belgium
| | - Guido T Bommer
- Metabolic Research Group, de Duve Institute, UCLouvain, B-1200, Brussels, Belgium
| | - Romain Boidot
- Unit of Molecular Biology, Department of Biology and Pathology of Tumors, Georges‑François Leclerc Cancer Center‑UNICANCER, 21079, Dijon, France
- ICMUB UMR CNRS 6302, 21079, Dijon, France
| | - Perrine Vermonden
- Louvain Institute of Biomolecular Science and Technology (LIBST), UCLouvain, Croix du Sud 4-5/L7.07.03, B-1348, Louvain-la-Neuve, Belgium
| | - Aurélien Warnant
- Louvain Institute of Biomolecular Science and Technology (LIBST), UCLouvain, Croix du Sud 4-5/L7.07.03, B-1348, Louvain-la-Neuve, Belgium
| | - Yvan Larondelle
- Louvain Institute of Biomolecular Science and Technology (LIBST), UCLouvain, Croix du Sud 4-5/L7.07.03, B-1348, Louvain-la-Neuve, Belgium
| | - Jean-Pascal Machiels
- King Albert II Cancer Institute, Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, B-1200, Brussels, Belgium
- Pole of Molecular Imaging, Radiotherapy and Oncology (MIRO), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B-1200, Brussels, Belgium
- Department of Head and Neck Surgery, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, B-1200, Brussels, Belgium
| | - Olivier Feron
- Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B1.57.04, B-1200, Brussels, Belgium
- WEL Research Institute, Avenue Pasteur 6, B-1300, Wavre, Belgium
| | - Sandra Schmitz
- King Albert II Cancer Institute, Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, B-1200, Brussels, Belgium
- Pole of Molecular Imaging, Radiotherapy and Oncology (MIRO), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B-1200, Brussels, Belgium
- Department of Head and Neck Surgery, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, B-1200, Brussels, Belgium
| | - Cyril Corbet
- Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B1.57.04, B-1200, Brussels, Belgium.
- WEL Research Institute, Avenue Pasteur 6, B-1300, Wavre, Belgium.
| |
Collapse
|
280
|
Ahmed FM, Shankar G, Jain A, G B. Effect of Tranexamic Acid in Reducing Seroma Formation and Drain Output After Modified Radical Mastectomy: A Double Blind Randomized Control Trial. Indian J Surg Oncol 2025; 16:190-197. [PMID: 40114901 PMCID: PMC11920523 DOI: 10.1007/s13193-024-02050-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2024] [Accepted: 07/25/2024] [Indexed: 03/22/2025] Open
Abstract
Seroma and high drain output is common complication after modified radical mastectomy (MRM). MRM leaves behind a negative space which fills up with fluid from cut lymphatics and tissue leading to seroma. Tranexamic acid decreases clot degradation thereby plugging the vessels leading to decreased seroma. This study is to determine if tranexamic acid reduces the incidence of seroma formation, drain output, and wound-related complications in post-operative cases of MRM. We conducted a prospective, double blinded, parallel arm, randomized control trial of 160 women with breast cancer undergoing MRM to study the effect of tranexamic in reducing seroma and drain output. Patients were recruited from a period of 2021-2022. Tranexamic acid was given 15 mg/kg IV at the time of administration of anaesthesia and 500 mg twice a day for 5 days with the control group receiving a placebo. The cases were followed up for a period of one month. Drain output, clinical seroma formation, and wound-related complications were recorded. There was a significant reduction in the drain output compared to the patients receiving a placebo (590 ml vs 725 ml: p = 0.001). The number of patients developing a clinically detectable seroma was also reduced (16.3% vs 31.3%: p = 0.025). Tranexamic acid also led to reduction in wound infection (6.3% vs 23.8%: p = 0.002). Wound dehiscence and flap necrosis was also lower in the tranexamic acid group, but it was not statistically significant. Our results show that tranexamic acid reduces seroma formation, facilitates early drain removal, and reduces the wound infection in patients undergoing MRM. Supplementary Information The online version contains supplementary material available at 10.1007/s13193-024-02050-5.
Collapse
Affiliation(s)
| | | | - Ankit Jain
- Department of General Surgery, Jipmer, Puducherry, India
| | | |
Collapse
|
281
|
Zhang Q, Wu Z, Song J, Luo S, Chai Z. Comprehensiveness of Large Language Models in Patient Queries on Gingival and Endodontic Health. Int Dent J 2025; 75:151-157. [PMID: 39147663 PMCID: PMC11806297 DOI: 10.1016/j.identj.2024.06.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2024] [Revised: 06/12/2024] [Accepted: 06/19/2024] [Indexed: 08/17/2024] Open
Abstract
AIM Given the increasing interest in using large language models (LLMs) for self-diagnosis, this study aimed to evaluate the comprehensiveness of two prominent LLMs, ChatGPT-3.5 and ChatGPT-4, in addressing common queries related to gingival and endodontic health across different language contexts and query types. METHODS We assembled a set of 33 common real-life questions related to gingival and endodontic healthcare, including 17 common-sense questions and 16 expert questions. Each question was presented to the LLMs in both English and Chinese. Three specialists were invited to evaluate the comprehensiveness of the responses on a five-point Likert scale, where a higher score indicated greater quality responses. RESULTS LLMs performed significantly better in English, with an average score of 4.53, compared to 3.95 in Chinese (Mann-Whitney U test, P < .05). Responses to common sense questions received higher scores than those to expert questions, with averages of 4.46 and 4.02 (Mann-Whitney U test, P < .05). Among the LLMs, ChatGPT-4 consistently outperformed ChatGPT-3.5, achieving average scores of 4.45 and 4.03 (Mann-Whitney U test, P < .05). CONCLUSIONS ChatGPT-4 provides more comprehensive responses than ChatGPT-3.5 for queries related to gingival and endodontic health. Both LLMs perform better in English and on common sense questions. However, the performance discrepancies across different language contexts and the presence of inaccurate responses suggest that further evaluation and understanding of their limitations are crucial to avoid potential misunderstandings. CLINICAL RELEVANCE This study revealed the performance differences of ChatGPT-3.5 and ChatGPT-4 in handling gingival and endodontic health issues across different language contexts, providing insights into the comprehensiveness and limitations of LLMs in addressing common oral healthcare queries.
Collapse
Affiliation(s)
- Qian Zhang
- College of Stomatology, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory for Oral Diseases and Biomedical Sciences, Chongqing, China; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing, China
| | - Zhengyu Wu
- College of Stomatology, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory for Oral Diseases and Biomedical Sciences, Chongqing, China; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing, China
| | - Jinlin Song
- College of Stomatology, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory for Oral Diseases and Biomedical Sciences, Chongqing, China; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing, China
| | - Shuicai Luo
- Quanzhou Institute of Equipment Manufacturing, Haixi Institute, Chinese Academy of Sciences, Quanzhou, China
| | - Zhaowu Chai
- College of Stomatology, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory for Oral Diseases and Biomedical Sciences, Chongqing, China; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing, China.
| |
Collapse
|
282
|
Goriacko P, Chao J, Fassbender P, Rudolph MI, Beechner P, Shukla H, Yaghdjian V, Choice C, Aroh F, Sinnett M, Karaye IM, Eikermann M. Optimizing neuromuscular block monitoring and reversal: A large-scale quality improvement initiative in a diverse healthcare setting. J Clin Anesth 2025; 101:111709. [PMID: 39671754 PMCID: PMC11750612 DOI: 10.1016/j.jclinane.2024.111709] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2024] [Revised: 11/15/2024] [Accepted: 11/28/2024] [Indexed: 12/15/2024]
Abstract
BACKGROUND Residual neuromuscular block (NMB) after anesthesia poses significant risk to patients, which can be reduced by adhering to evidence-based practices for the dosing, monitoring, and reversal of NMB. Incorporation of best practices into routine clinical care remains uneven across providers and institutions, prompting the need for effective implementation strategies. METHODS An interdisciplinary quality improvement initiative aimed to optimize NMB reversal practices across a large multi-campus urban medical center. Using the Institute for Healthcare Improvement (IHI) framework, interventions were designed to increase Train-of-Four (TOF) monitoring and promote evidence-based and cost-effective use of the NMB reversal agents. Process and outcome measures were tracked through Plan-Do-Study-Act (PDSA) cycles. Qualitative interviews provided insights into clinician perspectives. RESULTS The study encompassed 35,198 surgical cases utilizing NMB agents. The interventions led to a sustained increase in TOF monitoring from 42 % to 83 %. Significant increases were also observed in TOF ratio documentation and utilization of sugammadex. Postoperative respiratory complication rates decreased by 41 % (RR 0.59, 95 % CI 0.32-0.96) over the course of the initiative. The most pronounced increases in TOF monitoring were associated with financial incentives for the achievement of department-wide target monitoring rate. CONCLUSION This initiative demonstrates successful large-scale integration of quantitative TOF monitoring and evidence based NMB management across a diverse medical center, while highlighting important barriers in implementation. These findings contribute to the broader discussion on translating evidence into practice, offering insights for improving patient care and safety through tailored implementation strategies.
Collapse
Affiliation(s)
- Pavel Goriacko
- Center for Health Data Innovations, Montefiore Einstein, 3 Odell Plaza, Yonkers, NY 10703, USA; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA.
| | - Jerry Chao
- Department of Anesthesiology, Montefiore Medical Center, 111 East 210(th) Street, Bronx, NY 10467, USA
| | - Philipp Fassbender
- Department of Anesthesiology, Montefiore Medical Center, 111 East 210(th) Street, Bronx, NY 10467, USA
| | - Maíra I Rudolph
- Department of Anesthesiology, Montefiore Medical Center, 111 East 210(th) Street, Bronx, NY 10467, USA
| | - Paul Beechner
- Center for Performance Improvement, Montefiore Network Performance Group, 6 Executive Plaza, Suite 112A, Yonkers, NY 10701, USA
| | - Harshal Shukla
- Department of Pharmacy, Montefiore Medical Center, 111 East 210(th) Street, Bronx, NY 10467, USA
| | - Vicken Yaghdjian
- Department of Pharmacy, Montefiore Medical Center, 111 East 210(th) Street, Bronx, NY 10467, USA
| | - Curtis Choice
- Department of Anesthesiology, Montefiore Medical Center, 111 East 210(th) Street, Bronx, NY 10467, USA
| | - Frank Aroh
- Department of Pharmacy, Montefiore Medical Center, 111 East 210(th) Street, Bronx, NY 10467, USA
| | - Mark Sinnett
- Department of Pharmacy, Montefiore Medical Center, 111 East 210(th) Street, Bronx, NY 10467, USA
| | - Ibraheem M Karaye
- Department of Anesthesiology, Montefiore Medical Center, 111 East 210(th) Street, Bronx, NY 10467, USA
| | - Matthias Eikermann
- Department of Anesthesiology, Montefiore Medical Center, 111 East 210(th) Street, Bronx, NY 10467, USA
| |
Collapse
|
283
|
Ottaiano A, Santorsola M, Sirica R, Mauro AD, Di Carlo A, Ianniello M, Sabbatino F, Castiello R, Peschio FD, Cascella M, Perri F, Capuozzo M, Martucci N, Mercadante E, Borzillo V, Di Franco R, Izzo F, Granata V, Picone C, Petrillo A, Berretta M, Stilo S, Tarotto L, Carratù AC, Ferrara G, Tathode M, Cossu AM, Bocchetti M, Caraglia M, Nasti G, Savarese G. Clinical and genetic drivers of oligo-metastatic disease in colon cancer. Neoplasia 2025; 60:101111. [PMID: 39709701 PMCID: PMC11846493 DOI: 10.1016/j.neo.2024.101111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2024] [Accepted: 12/17/2024] [Indexed: 12/24/2024]
Abstract
BACKGROUND Oligo-metastatic disease (OMD) in colon cancer patients exhibits distinct clinical behavior compared to poly-metastatic disease (PMD), with a more responsive and indolent course. This study aims to identify clinical and biological factors uniquely associated with oligo-metastatic behavior. METHODS Metastatic colon cancer patients from an academic center underwent genetic characterization. OMD was defined as ≤3 lesions per organ, each with a total diameter <70 mm and none exceeding 25 mm. Tumor DNA sequencing by NGS utilized the TruSight Oncology 500 kit. Overall survival (OS) was determined from metastasis diagnosis until death using Kaplan-Meier analysis. Multivariate Cox regression examined prognostic links between clinicopathological and genetic factors. Associations with metastatic patterns were evaluated using Chi-square. RESULTS The analysis involved 104 patients (44 with OMD, 60 with PMD). OMD was more prevalent in males (P = 0.0299) and with single organ involvement (P = 0.0226). Multivariate analysis adjusted for age (>70 vs. <70 years), gender (male vs. female), tumor side (right vs. left), metastatic involvement (more than one site vs. one site), response to first-line therapy (disease control vs. no disease control), and RAS/BRAF variants (wild-type vs. mutated) identified OMD vs. PMD as the strongest independent predictor of survival (HR: 0.14; 95 % CI: 0.06-0.33; P<0.0001). OMD patients exhibited distinct molecular characteristics, including lower frequencies of BRAF p.V600E (P=0.0315) and KRAS mutations (P=0.0456), as well as a higher frequency of high tumor mutational burden (P=0.0127). Additionally, by integrating data from public datasets and our case study, we hypothesize that some gene alterations (i.e.: BRAF, SMAD4, RAF1, and mTOR) may prevent OMD occurrence. CONCLUSION OMD, characterized by male predominance, single-site involvement, and distinct molecular features in colon cancer, suggests the need for tailored management strategies.
Collapse
Affiliation(s)
- Alessandro Ottaiano
- SSD-Innovative Therapies for Abdominal Metastases, IRCCS "G. Pascale", Istituto Nazionale Tumori di Napoli, Via M. Semmola, Naples 80131, Italy.
| | - Mariachiara Santorsola
- SSD-Innovative Therapies for Abdominal Metastases, IRCCS "G. Pascale", Istituto Nazionale Tumori di Napoli, Via M. Semmola, Naples 80131, Italy
| | - Roberto Sirica
- AMES, Centro Polidiagnostico Strumentale srl, Via Padre Carmine Fico 24, Casalnuovo Di Napoli 80013, Italy
| | - Annabella Di Mauro
- Unit of Pathology, IRCCS "G. Pascale", Istituto Nazionale Tumori di Napoli, Via M. Semmola, Naples 80131, Italy
| | - Antonella Di Carlo
- AMES, Centro Polidiagnostico Strumentale srl, Via Padre Carmine Fico 24, Casalnuovo Di Napoli 80013, Italy
| | - Monica Ianniello
- AMES, Centro Polidiagnostico Strumentale srl, Via Padre Carmine Fico 24, Casalnuovo Di Napoli 80013, Italy
| | - Francesco Sabbatino
- Medical Oncology, Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi 84081, Italy
| | - Rosa Castiello
- AMES, Centro Polidiagnostico Strumentale srl, Via Padre Carmine Fico 24, Casalnuovo Di Napoli 80013, Italy
| | - Francesca Del Peschio
- AMES, Centro Polidiagnostico Strumentale srl, Via Padre Carmine Fico 24, Casalnuovo Di Napoli 80013, Italy
| | - Marco Cascella
- Unit of Anesthesia and Pain Medicine, Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi 84081, Italy
| | - Francesco Perri
- Medical and Experimental Head and Neck Oncology Unit, IRCCS "G. Pascale", Istituto Nazionale Tumori di Napoli, Via M. Semmola, Naples 80131, Italy
| | | | - Nicola Martucci
- Unit of Thoracic Surgery, Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale", Via M. Semmola, Naples 80131, Italy
| | - Edoardo Mercadante
- Unit of Thoracic Surgery, Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale", Via M. Semmola, Naples 80131, Italy
| | - Valentina Borzillo
- Department of Radiation Oncology, IRCCS "G. Pascale", Istituto Nazionale Tumori di Napoli, Via M. Semmola, Naples 80131, Italy
| | - Rossella Di Franco
- Department of Radiation Oncology, IRCCS "G. Pascale", Istituto Nazionale Tumori di Napoli, Via M. Semmola, Naples 80131, Italy
| | - Francesco Izzo
- Unit of Epato-Biliary Surgery, Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale", Via M. Semmola, Naples 80131, Italy
| | - Vincenza Granata
- Unit of Radiology, Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale", Via M. Semmola, Naples 80131, Italy
| | - Carmine Picone
- Unit of Radiology, Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale", Via M. Semmola, Naples 80131, Italy
| | - Antonella Petrillo
- Unit of Radiology, Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale", Via M. Semmola, Naples 80131, Italy
| | - Massimiliano Berretta
- Department of Clinical and Experimental Medicine, University of Messina, Messina 98122, Italy
| | - Salvatore Stilo
- Interventional Radiology Unit, Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale", Via M. Semmola, Naples 80131, Italy
| | - Luca Tarotto
- Interventional Radiology Unit, Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale", Via M. Semmola, Naples 80131, Italy
| | - Anna Chiara Carratù
- SSD-Innovative Therapies for Abdominal Metastases, IRCCS "G. Pascale", Istituto Nazionale Tumori di Napoli, Via M. Semmola, Naples 80131, Italy
| | - Gerardo Ferrara
- Unit of Pathology, IRCCS "G. Pascale", Istituto Nazionale Tumori di Napoli, Via M. Semmola, Naples 80131, Italy
| | - Madhura Tathode
- Department of Precision Medicine, University of Campania "L. Vanvitelli", Via Luigi De Crecchio 7, Naples 80138, Italy; Laboratory of Precision and Molecular Oncology, Biogem Scarl IRGS, Ariano Irpino, Italy
| | - Alessia Maria Cossu
- Department of Precision Medicine, University of Campania "L. Vanvitelli", Via Luigi De Crecchio 7, Naples 80138, Italy; Laboratory of Precision and Molecular Oncology, Biogem Scarl IRGS, Ariano Irpino, Italy
| | - Marco Bocchetti
- Department of Precision Medicine, University of Campania "L. Vanvitelli", Via Luigi De Crecchio 7, Naples 80138, Italy; Laboratory of Precision and Molecular Oncology, Biogem Scarl IRGS, Ariano Irpino, Italy
| | - Michele Caraglia
- Department of Precision Medicine, University of Campania "L. Vanvitelli", Via Luigi De Crecchio 7, Naples 80138, Italy; Laboratory of Precision and Molecular Oncology, Biogem Scarl IRGS, Ariano Irpino, Italy
| | - Guglielmo Nasti
- SSD-Innovative Therapies for Abdominal Metastases, IRCCS "G. Pascale", Istituto Nazionale Tumori di Napoli, Via M. Semmola, Naples 80131, Italy
| | - Giovanni Savarese
- AMES, Centro Polidiagnostico Strumentale srl, Via Padre Carmine Fico 24, Casalnuovo Di Napoli 80013, Italy
| |
Collapse
|
284
|
De Rosa S, Bignami E, Bellini V, Battaglini D. The Future of Artificial Intelligence Using Images and Clinical Assessment for Difficult Airway Management. Anesth Analg 2025; 140:317-325. [PMID: 38557728 PMCID: PMC11687942 DOI: 10.1213/ane.0000000000006969] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/13/2024] [Indexed: 04/04/2024]
Abstract
Artificial intelligence (AI) algorithms, particularly deep learning, are automatic and sophisticated methods that recognize complex patterns in imaging data providing high qualitative assessments. Several machine-learning and deep-learning models using imaging techniques have been recently developed and validated to predict difficult airways. Despite advances in AI modeling. In this review article, we describe the advantages of using AI models. We explore how these methods could impact clinical practice. Finally, we discuss predictive modeling for difficult laryngoscopy using machine-learning and the future approach with intelligent intubation devices.
Collapse
Affiliation(s)
- Silvia De Rosa
- From the Centre for Medical Sciences – CISMed, University of Trento, Trento, Italy
- Anesthesia and Intensive Care, Santa Chiara Regional Hospital, APSS Trento, Trento, Italy
| | - Elena Bignami
- Anesthesiology, Critical Care and Pain Medicine Division, Department of Medicine and Surgery, University of Parma, Parma, Italy
| | - Valentina Bellini
- Anesthesiology, Critical Care and Pain Medicine Division, Department of Medicine and Surgery, University of Parma, Parma, Italy
| | - Denise Battaglini
- Anesthesia and Intensive Care, IRCCS Ospedale Policlinico San Martino, Genova, Italy
| |
Collapse
|
285
|
Bijkerk V, Krijtenburg P, Verweijen T, Bruhn J, Scheffer GJ, Keijzer C, Warlé MC. Residual neuromuscular block in the postanaesthesia care unit: a single-centre prospective observational study and systematic review. Br J Anaesth 2025; 134:350-357. [PMID: 39443187 DOI: 10.1016/j.bja.2024.07.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2024] [Revised: 07/23/2024] [Accepted: 07/24/2024] [Indexed: 10/25/2024] Open
Abstract
BACKGROUND Concerns regarding residual neuromuscular block (RNMB) have persisted since the introduction of neuromuscular blocking agents, with reported incidences in the 21st century up to 50%. Advances in neuromuscular transmission (NMT) monitoring and the introduction of sugammadex have addressed this issue, but the impact of these developments remains unclear. METHODS This prospective observational study evaluated RNMB in 500 surgical patients in a large Dutch teaching hospital with readily available quantitative NMT monitoring and reversal agents. The anaesthetic technique and intraoperative NMT monitoring were independently chosen by the attending anaesthesiologist. Acceleromyography was performed upon arrival in the PACU for patients who received nondepolarising neuromuscular blocking agents. RNMB was defined as a train-of-four ratio (TOFR) <0.9. A systematic review was conducted to analyse trends in RNMB in contemporary practice. RESULTS Out of 500 patients, 11 (2.2%) had a TOFR <0.9. Intraoperative NMT monitoring was performed in 77.6% of patients, and sugammadex was administered to 38% of patients. No patient received neostigmine. The only difference was an automatically recorded TOFR ≥0.9 at the end of surgery in 61.1% in the non-RNMB group compared with 18.2% in the RNMB group (P=0.009). Our systematic review identified incidences ranging from 3.5% to 53.3% since 2000, with a decreasing trend in Europe and North America. CONCLUSIONS The incidence of residual neuromuscular block in the PACU was 2.2%. This suggests significant improvement in the prevention of residual neuromuscular block and stresses the importance of rigorous neuromuscular transmission monitoring and adequate use of reversal agents.
Collapse
Affiliation(s)
- Veerle Bijkerk
- Department of Anaesthesiology, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands.
| | - Piet Krijtenburg
- Department of Anaesthesiology, Radboud University Medical Centre, Nijmegen, The Netherlands
| | - Tessa Verweijen
- Department of Anaesthesiology, Radboud University Medical Centre, Nijmegen, The Netherlands
| | - Jörgen Bruhn
- Department of Anaesthesiology, Radboud University Medical Centre, Nijmegen, The Netherlands
| | - Gert Jan Scheffer
- Department of Anaesthesiology, Radboud University Medical Centre, Nijmegen, The Netherlands
| | - Christiaan Keijzer
- Department of Anaesthesiology, Radboud University Medical Centre, Nijmegen, The Netherlands
| | - Michiel C Warlé
- Department of Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands
| |
Collapse
|
286
|
Xu J, Wu M, Duan B, Ni Y, Wang A. The Analgesic Effect of a Transdermal Lappaconitine Patch Combined With Ibuprofen Suspension for Children After Adenoidectomy and Tonsillectomy: A Randomized Clinical Trial. J Perianesth Nurs 2025; 40:126-133. [PMID: 38980239 DOI: 10.1016/j.jopan.2024.03.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2023] [Revised: 03/20/2024] [Accepted: 03/29/2024] [Indexed: 07/10/2024]
Abstract
PURPOSE To study the analgesic effects and side effects of a transdermal lappaconitine (TLA) patch, ibuprofen suspension (IS), and TLA combined with IS (TLACIS) after adenoidectomy and tonsillectomy. DESIGN Prospective, randomized clinical trial. METHODS The patients were randomized into three groups defined by different analgesic drug regimens: the TLA group, the IS group, and the TLACIS group. Pain scores at 2, 12, and 24 hours after surgery and adverse-event reports within the first postoperative week were collected. RESULTS Ultimately, this study included 102 cases in the TLA group, 101 cases in the IS group, and 101 cases in the TLACIS group. At 2 hours after surgery, the pain scores of the TLA and the TLACIS groups were both significantly lower than that of the IS group (all P < .05). At 12 and 24 hours after surgery, the pain score of the TLACIS group was significantly lower than those of the TLA and IS groups (all P < .05); furthermore, the pain score of the IS group was significantly lower than that of the TLA group (P < .05). Within 1 week after the operation, there was no significant difference in the incidence of adverse events. CONCLUSIONS The addition of a TLA patch can speed the onset of analgesia. In terms of analgesic effects, IS alone is more advantageous than TLA alone, while the combination of TLA and IS has the best analgesic effect. No significant differences were found in the incidence of adverse events among the three regimens.
Collapse
Affiliation(s)
- Jiayuan Xu
- Department of Nursing, Children's Hospital of Fudan University, Shanghai, China
| | - Min Wu
- Department of Nursing, Children's Hospital of Fudan University, Shanghai, China
| | - Bo Duan
- Department of Nursing, Children's Hospital of Fudan University, Shanghai, China
| | - Yihua Ni
- Department of Nursing, Children's Hospital of Fudan University, Shanghai, China
| | - Anken Wang
- Department of Nursing, Children's Hospital of Fudan University, Shanghai, China.
| |
Collapse
|
287
|
Bignami EG, Panizzi M, Bellini V. Letter to the Editor in Response to Ha, L.T. et al. "Artificial Intelligence: Promise or Pitfalls? A Clinical Vignette of Real-Life ChatGPT Implementation in Perioperative Medicine". J Gen Intern Med 2025; 40:491. [PMID: 39438375 PMCID: PMC11803018 DOI: 10.1007/s11606-024-09145-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/22/2024] [Accepted: 10/11/2024] [Indexed: 10/25/2024]
Affiliation(s)
- E G Bignami
- Anesthesiology, Critical Care and Pain Medicine Division, Department of Medicine and Surgery, University of Parma, Viale Gramsci 14, 43126, Parma, Italy.
| | - M Panizzi
- Anesthesiology, Critical Care and Pain Medicine Division, Department of Medicine and Surgery, University of Parma, Viale Gramsci 14, 43126, Parma, Italy
| | - V Bellini
- Anesthesiology, Critical Care and Pain Medicine Division, Department of Medicine and Surgery, University of Parma, Viale Gramsci 14, 43126, Parma, Italy
| |
Collapse
|
288
|
Massironi S, Panzuto F, Zilli A, Rinzivillo M, Ciliberto A, Romano E, Danese S, Laviano A. Nutritional aspects in neuroendocrine neoplasms. bridging the gap between dietary interventions and cancer care strategies: a scoping review. J Endocrinol Invest 2025; 48:269-281. [PMID: 39395115 PMCID: PMC11785655 DOI: 10.1007/s40618-024-02462-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/11/2024] [Accepted: 08/26/2024] [Indexed: 10/14/2024]
Abstract
PURPOSE Neuroendocrine neoplasms (NENs) represent heterogeneous tumors arising from neuroendocrine cells in different organs. Despite growing interest in the nutritional aspects of NEN management, research in this area is limited. Aim of this review is to summarize the current state of knowledge, highlight research gaps, and underscore the significance of nutrition in the comprehensive care of NEN patients. METHODS We conducted an extensive bibliographic search focusing on studies (including retrospective and prospective studies, systematic reviews, case series, and guidelines) exploring the relationship between nutritional assessments, dietary interventions, micronutrient deficiencies, and their impact on NEN outcomes. RESULTS Significant gaps exist in current research, particularly in understanding the specific nutritional needs of NEN patients and how tailored nutritional interventions can improve clinical outcomes. Evidence suggests that a high-fat Western diet may promote the growth of NEN, while a Mediterranean diet may help lower insulin levels and strengthen the immune system, potentially preventing tumor development. The ketogenic diet and intermittent fasting may also have positive impacts. Addressing common micronutrient deficiencies, such as vitamin D and niacin, is crucial to mitigate disease progression. There's a crucial need for future studies to include a comprehensive nutritional assessment incorporating patient-reported outcomes, to fully capture the impact of nutritional strategies. CONCLUSION Nutritional management, an important but under-researched facet of NEN treatment, significantly improves patients' quality of life and survival. Integrating nutrition into personalized cancer care is essential, highlighting the role of nutritional strategies in optimizing patient outcomes.
Collapse
Affiliation(s)
- Sara Massironi
- Division of Gastroenterology Fondazione, IRCCS San Gerardo dei Tintori, Monza, Italia.
- Division of Gastroenterology, San Gerardo Hospital, Via Pergolesi 3, Monza, Italy.
| | - Francesco Panzuto
- Department of Surgical-Medical Sciences and Translational Medicine, Digestive Disease Unit, Sapienza University of Rome, Sant'Andrea University Hospital, ENETS Center of Excellence, Rome, Italy
| | - Alessandra Zilli
- Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital, Milan, Italy
| | - Maria Rinzivillo
- Department of Surgical-Medical Sciences and Translational Medicine, Digestive Disease Unit, Sapienza University of Rome, Sant'Andrea University Hospital, ENETS Center of Excellence, Rome, Italy
| | - Ambra Ciliberto
- Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital, Milan, Italy
| | - Elena Romano
- Department of Surgical-Medical Sciences and Translational Medicine, Digestive Disease Unit, Sapienza University of Rome, Sant'Andrea University Hospital, ENETS Center of Excellence, Rome, Italy
| | - Silvio Danese
- Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital, Milan, Italy
- Vita-Salute San Raffaele University, Milan, Italy
| | - Alessandro Laviano
- Department of Translational and Precision Medicine, Clinical Nutrition Unit, Sapienza University of Rome, Sant'Andrea University Hospital, Rome, Italy
| |
Collapse
|
289
|
Bortoletto R, Comacchio C, Garzitto M, Piscitelli F, Balestrieri M, Colizzi M. Palmitoylethanolamide supplementation for human health: A state-of-the-art systematic review of Randomized Controlled Trials in patient populations. Brain Behav Immun Health 2025; 43:100927. [PMID: 39839988 PMCID: PMC11745966 DOI: 10.1016/j.bbih.2024.100927] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2024] [Revised: 12/11/2024] [Accepted: 12/21/2024] [Indexed: 01/03/2025] Open
Abstract
Interest in preventative dietary interventions for human health has increasingly focused on the endocannabinoid (eCB)-like compound palmitoylethanolamide (PEA), a bioactive lipid mediator with anti-inflammatory, analgesic, and neuroprotective properties. This Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020-compliant systematic review aimed at collecting and comprehensively discussing all available data from Randomized Controlled Trials (RCTs) evaluating the efficacy and tolerability of PEA supplementation across human illnesses in patient populations. Overall, 48 eligible outputs from 47 RCTs were extracted, covering neuropsychiatric (n = 15), neurological (n = 17), somatic (n = 13), and visceral (n = 11) disturbances, as well as PEA effects on blood/plasma or other tissue biomarkers (n = 10). The strongest evidence emerged from RCTs exploring PEA impact on pain management and measures of general wellbeing, especially in its ultramicronized/micronized or cold-water dispersible formulations, showing good tolerability compared to controls. Also, alongside symptom improvement, PEA demonstrated to modulate biomarkers early altered in the initial phases of an illness or contributing to its progression, suggesting a disease-modifying potential. This systematic review provided a comprehensive overview of the therapeutic potential of PEA across RCTs, highlighting its versatility either as monotherapy or add-on treatment for various clinical conditions.
Collapse
Affiliation(s)
- R. Bortoletto
- Unit of Psychiatry and Eating Disorders, Department of Medicine (DMED), University of Udine, Udine, Italy
| | - C. Comacchio
- Unit of Psychiatry and Eating Disorders, Department of Medicine (DMED), University of Udine, Udine, Italy
| | - M. Garzitto
- Unit of Psychiatry and Eating Disorders, Department of Medicine (DMED), University of Udine, Udine, Italy
| | - F. Piscitelli
- Institute of Biomolecular Chemistry, National Research Council (CNR), Pozzuoli, Italy
| | - M. Balestrieri
- Unit of Psychiatry and Eating Disorders, Department of Medicine (DMED), University of Udine, Udine, Italy
| | - M. Colizzi
- Unit of Psychiatry and Eating Disorders, Department of Medicine (DMED), University of Udine, Udine, Italy
- Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| |
Collapse
|
290
|
Hatano H, Yoshida T, Higashiyama R, Torasawa M, Uehara Y, Ohe Y. EGFR, TP53, and CUL3 Triple Mutation in Non-Small Cell Lung Cancer and its Potentially Poor Prognosis: A Case Report and Database Analysis. Thorac Cancer 2025; 16:e15523. [PMID: 39727229 PMCID: PMC11788012 DOI: 10.1111/1759-7714.15523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2024] [Revised: 12/11/2024] [Accepted: 12/15/2024] [Indexed: 12/28/2024] Open
Abstract
Concurrent mutations in tumor protein p53 (TP53) or Kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2-pathway components are linked to poor outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), but the impact of triple mutations remains unclear. We report a case of EGFR-, TP53-, and Cullin 3 (CUL3)-mutant NSCLC in a 43-year-old woman with widespread metastases at diagnosis, including those in the contralateral lung, distant lymph nodes, pericardium, liver, bones, left adrenal gland, and brain. She received osimertinib as first-line therapy, but pericardial effusion and liver metastases progressed rapidly over 3 months, and she was switched to carboplatin and pemetrexed. By the eighth cycle of pemetrexed, the bone metastases had progressed, resulting in disseminated intravascular coagulation (DIC) due to bone marrow carcinomatosis. The patient received third-line therapy with albumin-bound paclitaxel and fourth-line therapy with docetaxel, but further treatment was suspended owing to DIC progression. She passed away 23 months after the initiation of osimertinib. Public database analysis revealed that the EGFR/TP53/CUL3 triple mutation accounts for 0.4% of EGFR-mutant NSCLC cases, yielding significantly shorter survival than EGFR mutations alone and likely shorter than EGFR/TP53 double mutations. Gaining a deeper understanding of the clinical significance of coexisting genetic mutations in patients with EGFR-mutant NSCLC will be crucial to develop future therapies.
Collapse
Affiliation(s)
- Hiroto Hatano
- Department of Thoracic OncologyNational Cancer Center HospitalTokyoJapan
- Department of Respiratory MedicineNational Center for Global Health and MedicineTokyoJapan
| | - Tatsuya Yoshida
- Department of Thoracic OncologyNational Cancer Center HospitalTokyoJapan
- Department of Experimental TherapeuticsNational Cancer Center HospitalTokyoJapan
| | - Ryoko Higashiyama
- Department of Thoracic OncologyNational Cancer Center HospitalTokyoJapan
- Department of Experimental TherapeuticsNational Cancer Center HospitalTokyoJapan
| | - Masahiro Torasawa
- Department of Thoracic OncologyNational Cancer Center HospitalTokyoJapan
| | - Yuji Uehara
- Department of Thoracic OncologyNational Cancer Center HospitalTokyoJapan
| | - Yuichiro Ohe
- Department of Thoracic OncologyNational Cancer Center HospitalTokyoJapan
| |
Collapse
|
291
|
Kong AYH, Liu N, Tan HS, Sia ATH, Sng BL. Artificial intelligence in obstetric anaesthesiology - the future of patient care? Int J Obstet Anesth 2025; 61:104288. [PMID: 39577145 DOI: 10.1016/j.ijoa.2024.104288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/07/2023] [Revised: 08/28/2024] [Accepted: 10/13/2024] [Indexed: 11/24/2024]
Abstract
The use of artificial intelligence (AI) in obstetric anaesthesiology shows great potential in enhancing our practice and delivery of care. In this narrative review, we summarise the current applications of AI in four key areas of obstetric anaesthesiology (perioperative care, neuraxial procedures, labour analgesia and obstetric critical care), where AI has been employed to varying degrees for decision support, event prediction, risk stratification and procedural assistance. We also identify gaps in current practice and propose areas for further research. While promising, AI cannot replace the expertise and clinical judgement of a trained obstetric anaesthesiologist. It should, instead, be viewed as a valuable tool to facilitate and support our practice.
Collapse
Affiliation(s)
- A Y H Kong
- Department of Women's Anaesthesia, KK Women's and Children's Hospital, Singapore.
| | - N Liu
- Centre for Quantitative Medicine and Programme in Health Services and Systems Research, Duke-NUS Medical School, Singapore
| | - H S Tan
- Department of Women's Anaesthesia, KK Women's and Children's Hospital, Singapore; Anaesthesiology and Perioperative Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore
| | - A T H Sia
- Department of Women's Anaesthesia, KK Women's and Children's Hospital, Singapore; Anaesthesiology and Perioperative Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore
| | - B L Sng
- Department of Women's Anaesthesia, KK Women's and Children's Hospital, Singapore; Anaesthesiology and Perioperative Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore
| |
Collapse
|
292
|
Alibudbud RC, Aruta JJBR, Sison KA, Guinto RR. Artificial intelligence in the era of planetary health: insights on its application for the climate change-mental health nexus in the Philippines. Int Rev Psychiatry 2025; 37:21-32. [PMID: 40035376 DOI: 10.1080/09540261.2024.2363373] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/22/2024] [Accepted: 05/29/2024] [Indexed: 03/05/2025]
Abstract
This review explores the transformative potential of Artificial Intelligence (AI) in the light of evolving threats to planetary health, particularly the dangers posed by the climate crisis and its emerging mental health impacts, in the context of a climate-vulnerable country such as the Philippines. This paper describes the country's mental health system, outlines the chronic systemic challenges that it faces, and discusses the intensifying and widening impacts of climate change on mental health. Integrated mental healthcare must be part of the climate adaptation response, particularly for vulnerable populations. AI holds promise for mental healthcare in the Philippines, and be a tool that can potentially aid in addressing the shortage of mental health professionals, improve service accessibility, and provide direct services in climate-affected communities. However, the incorporation of AI into mental healthcare also presents significant challenges, such as potentially worsening the existing mental health inequities due to unequal access to resources and technologies, data privacy concerns, and potential AI algorithm biases. It is crucial to approach AI integration with ethical consideration and responsible implementation to harness its benefits, mitigate potential risks, and ensure inclusivity in mental healthcare delivery, especially in the era of a warming planet.
Collapse
Affiliation(s)
- Rowalt C Alibudbud
- Department of Sociology and Behavioral Sciences, De La Salle University, Manila, Philippines
| | | | - Kevin Anthony Sison
- St. Luke's Medical Center College of Medicine, William H. Quasha Memorial, Quezon City, Philippines
| | - Renzo R Guinto
- St. Luke's Medical Center College of Medicine, William H. Quasha Memorial, Quezon City, Philippines
- SingHealth Duke-NUS Global Health Institute, Duke-NUS Medical School, National University of Singapore, Singapore
| |
Collapse
|
293
|
Leoni MLG, Occhigrossi F, Tenti M, Raffaeli W. Endoscopic Epidurolysis for the Management of Chronic Spinal Pain: A Delphi-Based Italian Experts Consensus. Pain Ther 2025; 14:339-357. [PMID: 39704782 PMCID: PMC11751267 DOI: 10.1007/s40122-024-00695-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2024] [Accepted: 11/28/2024] [Indexed: 12/21/2024] Open
Abstract
INTRODUCTION Endoscopic epidurolysis (EE) is a minimally invasive procedure used to manage chronic spinal pain, particularly in cases unresponsive to traditional treatments. Despite its growing recognition, the literature lacks comprehensive guidelines on its optimal use. This study utilized a modified Delphi approach to gather expert consensus on best practices for EE in the Italian pain therapy network. METHODS The study's scientific board conducted an extensive literature review to define key investigation topics, including clinical indications, preoperative assessments, and technical aspects of EE. A semi-structured questionnaire was developed and administered to a panel of experts. A two-round Delphi process was implemented, with consensus defined as at least 70% agreement on a 7-point Likert scale (agree or strongly agree). Statements that did not reach consensus in the first round were rephrased and resubmitted in the second round. RESULTS Twenty-six clinicians participated in the study, with a 100% response rate in both rounds. In the first round, consensus was achieved for 9 out of 19 statements. In the second round, 8 out of 10 rephrased statements reached the consensus threshold. Key areas of agreement included the clinical indications for EE, the importance of preoperative imaging and anesthetic assessments, and the use of specific techniques and tools for EE. However, consensus was not reached on the use of EE for disc herniation with radicular pain and the safety of interlaminar access compared to sacral hiatus access. CONCLUSION The study highlights the need for standardized protocols in EE to ensure consistent and effective treatment of chronic spinal pain. The consensus reached by the expert panel provides a framework for best practices, which can guide clinical decision-making and improve patient outcomes. Further research is necessary to validate these findings and address areas where consensus was not achieved.
Collapse
Affiliation(s)
- Matteo Luigi Giuseppe Leoni
- Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, Rome, Italy
- Unit of Interventional and Surgical Pain Management, Guglielmo da Saliceto Hospital, Piacenza, Italy
| | | | - Michael Tenti
- Institute for Research on Pain, ISAL Foundation, 47921, Rimini, Italy.
| | - William Raffaeli
- Institute for Research on Pain, ISAL Foundation, 47921, Rimini, Italy
| |
Collapse
|
294
|
Gili-Ortiz E, Franco-Fernández D, Loli-Aznarán O, Gili-Miner M. Prevalence of burnout syndrome in European and North American anesthesiologists: A systematic review and meta-analysis. REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION 2025; 72:501665. [PMID: 39863127 DOI: 10.1016/j.redare.2025.501665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2024] [Accepted: 08/29/2024] [Indexed: 01/27/2025]
Abstract
AIMS The prevalence of burnout syndrome dimensions in anesthesiologists show notable international differences. In this study, mean prevalences of European and North American anesthesiologists are compared. METHODS Quantitative systematic review (meta-analysis) following the PRISMA and MOOSE criteria. Only studies made with the Maslach Burnout Inventory that includes a Human Services Survey (MBI-HSS) were included. The quality of the studies was evaluated with a modified Newcastle-Ottawa scale, which was used in the meta-regression analyzes together with the Healthcare Access and Quality Index (HAQI) and Gross National Income (GNI) indicators for each country. Publication bias due to small size studies was evaluated with the Egger test. RESULTS The means of Emotional Exhaustion and Depersonalization were lower in anesthesiologists from Western Europe than in those from Eastern Europe and North America, but the differences were only statistically significant in the Emotional Exhaustion dimension. Meta-regression results were not statistically significant in any of the burnout dimensions for any of the three moderating variables. The test for publication bias was not statistically significant in any of the three dimensions. CONCLUSIONS Based on the results of the meta-analysis and the information from the included studies, social and organizational factors are the most important etiological factors that explain the differences in prevalence. Some of them are related specifically to Eastern Europe and other factors are more relevant in North America. These differences are discussed in this paper.
Collapse
Affiliation(s)
- E Gili-Ortiz
- Servicio de Anestesiología, Reanimación y Terapéutica del Dolor, Hospital Can Misses, Ibiza, Balearic Islands, Spain.
| | - D Franco-Fernández
- Departamento de Psiquiatría, Facultad de Medicina, Universidad de Sevilla, Seville, Spain
| | - O Loli-Aznarán
- Servicio de Anestesiología, Reanimación y Terapéutica del Dolor, Hospital Can Misses, Ibiza, Balearic Islands, Spain
| | | |
Collapse
|
295
|
Ebert MT, Szpernal J, Vogt JA, Lien CA, Ebert TJ. Improving quantitative neuromuscular monitoring: an education initiative on stimulating electrode placement. J Clin Monit Comput 2025; 39:169-174. [PMID: 39433701 DOI: 10.1007/s10877-024-01227-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2024] [Accepted: 09/21/2024] [Indexed: 10/23/2024]
Abstract
Quantitative neuromuscular monitoring reduces the incidence of residual neuromuscular block, but broad acceptance of monitoring has been elusive despite recommendations for quantitative monitoring for decades. Acceptance of quantitative monitoring may, in part, be related to the quality of the data from monitoring systems. This evaluation explored proper stimulating electrode positioning for electromyographic (EMG) monitoring, the impact of an educational intervention on electrode positioning and anesthesia provider (anesthesiologist, resident, anesthetist) confidence in the monitoring data from the device. In a single-center, observations of EMG electrode placement by anesthesia technicians, in 55 adult elective surgery patients were made by an independent observer. Separately, the anesthesia provider satisfaction with EMG derived data was recorded after reversal of neuromuscular block. An educational intervention then occurred on proper electrode positioning, including prior observations of electrode positioning, and prior anesthesia provider satisfaction with the EMG derived data. After the intervention, stimulating electrode position was observed with an additional 60 patients and anesthesia provider satisfaction with the data was again ascertained. The educational intervention significantly increased the proportion of ideal ulnar nerve groove electrode positioning from 74.5% to 95% (P < 0.003) and ideal wrist crease positioning (distal electrode within 2 cm of crease) from 61.8% to 96.7% (P < 0.001). Anesthesia provider confidence with EMG derived information during anesthesia delivery, increased from 67 to 90% after the education (P = 0.005). There was a significant relationship between correct stimulating electrode placement and anesthesia provider confidence in the EMG derived data on neuromuscular block status. An educational intervention to improve EMG electrode positioning proved meaningful. It increased anesthesia provider confidence in the EMG derived data during anesthesia case management.
Collapse
Affiliation(s)
| | | | - Julia A Vogt
- Department of Anesthesiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI, 53226, USA
| | - Cynthia A Lien
- Zablocki VA Medical Center, Milwaukee, WI, USA
- Department of Anesthesiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI, 53226, USA
| | - Thomas J Ebert
- Zablocki VA Medical Center, Milwaukee, WI, USA.
- Department of Anesthesiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI, 53226, USA.
| |
Collapse
|
296
|
Soumik Saha P, Yan J, Zhu C. Portable multi-parametric microscopy for noninvasive metabolic and vascular imaging of orthotopic tongue cancer models in vivo. JOURNAL OF BIOMEDICAL OPTICS 2025; 30:S23905. [PMID: 40270786 PMCID: PMC12017805 DOI: 10.1117/1.jbo.30.s2.s23905] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/15/2024] [Revised: 03/12/2025] [Accepted: 03/31/2025] [Indexed: 04/25/2025]
Abstract
Significance Precise imaging of tumor metabolism with its vascular microenvironment becomes emerging critical for cancer research because increasing evidence shows that the key attribute that allows a tumor to survive therapies is metabolic and vascular reprogramming. However, there are surprisingly few imaging techniques available to provide a systems-level view of tumor metabolism and vasculature in vivo on small animals for cancer discoveries. Aim We aim to develop a new multi-parametric microscope that can faithfully recapitulate in vivo metabolic and vascular changes with a wide field of view and microscope-level resolution to advance cancer-related investigations. To maximize the ease and accessibility of obtaining in vivo tissue metabolism and vasculature measurements, we aim to develop our new metabolic imaging tool with minimal cost and size, allowing one to easily quantify tissue metabolic and vascular endpoints together in vivo, advancing many critical biomedical inquiries. Approach We have combined fluorescence microscopy and dark-field microscopy in a re-emission geometry into one portable microscope to image the key metabolic and vascular endpoints on the same tissue site. The portable microscope was first characterized by tissue-mimicking phantoms. Then the multi-parametric system was demonstrated on small animals to image glucose uptake (using 2-NBDG) and mitochondrial membrane potential (using TMRE) along with vascular parameters (oxygen saturation and hemoglobin contents) of orthotopic tongue tumors in vivo. Results Our phantom studies demonstrated the capability of the portable microscope for effective measurements of several key vascular and metabolic parameters with a comparable accuracy compared with our former reported benchtop spectroscopy and imaging systems. Our in vivo animal studies revealed increased glucose uptake and mitochondrial membrane potential along with reduced vascular oxygenation in tongue tumors compared with normal tongue tissues. The spatial analysis of metabolic and vascular images showed a more heterogeneous metabolic and oxygenation profile in tongue tumors compared with normal tongue tissues. Conclusions Our in vivo animal studies demonstrated the capability of our portable multi-parametric microscope for imaging the key metabolic and vascular parameters at the same tissue site with about one hour delay using an orthotopic tongue tumor model in vivo. Our study showed the potential of a portable functional microscope to noninvasively evaluate tumor biology using orthotopic tongue cancer models for future head and neck cancer research.
Collapse
Affiliation(s)
- Pranto Soumik Saha
- University of Kentucky, Department of Biomedical Engineering, Lexington, Kentucky, United States
| | - Jing Yan
- University of Kentucky, Department of Biomedical Engineering, Lexington, Kentucky, United States
| | - Caigang Zhu
- University of Kentucky, Department of Biomedical Engineering, Lexington, Kentucky, United States
| |
Collapse
|
297
|
Leng Y, Yang Y, Liu J, Jiang J, Zhou C. Evaluating the Feasibility of ChatGPT-4 as a Knowledge Resource in Bariatric Surgery: A Preliminary Assessment. Obes Surg 2025; 35:645-650. [PMID: 39821906 DOI: 10.1007/s11695-024-07666-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2024] [Revised: 12/29/2024] [Accepted: 12/31/2024] [Indexed: 01/19/2025]
Abstract
This study evaluates the feasibility of ChatGPT-4 as a knowledge resource in bariatric surgery. Using a problem set of 30 questions covering key aspects of bariatric care, responses were reviewed by three bariatric surgery experts. ChatGPT-4 achieved strong performance, with 50% of responses scoring the highest possible rating for alignment with clinical guidelines. However, limitations were noted, including outdated criteria, lack of specificity, and occasional poor response structuring. The study highlights the potential of ChatGPT-4 as a supplementary tool for patient education and healthcare provider support, as well as its broader public health applications, such as obesity prevention and healthy lifestyle education. Despite its promise, challenges such as handling complex clinical cases, reliance on up-to-date evidence, and ethical concerns like privacy and misinformation must be addressed. Future research should refine the model's applications and explore its integration into clinical practice and public health strategies.
Collapse
Affiliation(s)
- Yu Leng
- Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China
- Research Center of Anesthesiology, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China
| | - Yaoxin Yang
- Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China
- Research Center of Anesthesiology, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China
| | - Jin Liu
- Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China
- Research Center of Anesthesiology, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China
| | - Jingyao Jiang
- Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China
- Research Center of Anesthesiology, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China
| | - Cheng Zhou
- Research Center of Anesthesiology, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.
| |
Collapse
|
298
|
Weaver JMJ, Patey SJ. Systemic anti-cancer therapy and anaesthesia: a narrative review. Anaesthesia 2025; 80 Suppl 2:12-24. [PMID: 39776428 DOI: 10.1111/anae.16522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/04/2024] [Indexed: 01/11/2025]
Abstract
INTRODUCTION Cancer research has revolutionised the treatment, quality of life and life expectancy of people living with cancer. Systemic anti-cancer treatments have expanded to involve not only cytotoxic drugs, but targeted drugs and immunotherapy. Although highly effective in many patients, these drugs can cause serious and sometimes life-threatening adverse reactions. As part of their treatment, many patients living with cancer will be offered both systemic anti-cancer therapy and surgery, and many patients will undergo recurrent episodes of both with the aims of cure, palliation or prolongation of life expectancy. It is important for anaesthetists to understand the effects of systemic anti-cancer therapy on their patients. METHODS An electronic literature search using was conducted in May 2024 for peer-reviewed articles in English. An initial search of the terms 'anaesthesia' and 'chemotherapy' revealed that existing review literature was tailored towards the neoadjuvant setting and prompted this review to include the complications of targeted therapies, emergency care and intra-operative administration of systemic anti-cancer therapy to reflect this evolving field. A narrative approach was taken to discuss common regimens and their complications. RESULTS The review encompasses a wide range of sub-topics including pharmacology; physiology; peri-operative medicine; specialist surgery; adverse events; and safety. Data from multicentre trials that form the basis of current treatment regimens and practice were prioritised during the selection process. Smaller studies, case series and case reports were included to illustrate the rarer but clinically significant adverse effects of specific therapies. CONCLUSIONS It is important for anaesthetists to have a comprehensive understanding of the effects of systemic anti-cancer therapies, including cytotoxic and immunotherapies. There are many potential toxicities and complications associated with these treatments, particularly in the context of emergency surgery and the administration of cytotoxic drugs within the operating theatre environment.
Collapse
|
299
|
Bordini M, Olsen JM, Siu JM, Macartney J, Wolter NE, Propst EJ, Matava CT. Transcutaneous carbon dioxide monitoring in children undergoing rigid bronchoscopy: a prospective blinded observational study. Can J Anaesth 2025; 72:273-284. [PMID: 39414716 DOI: 10.1007/s12630-024-02862-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2024] [Revised: 07/19/2024] [Accepted: 07/22/2024] [Indexed: 10/18/2024] Open
Abstract
PURPOSE Anesthetic management during rigid bronchoscopy in children can be challenging, and continuous end-tidal carbon dioxide (EtCO2) monitoring is often unachievable. Transcutaneous carbon dioxide (TcCO2) monitoring is strongly correlated with the partial pressure of carbon dioxide (PaCO2) and EtCO2. We aimed to investigate the incidence of hypercapnia in children undergoing rigid bronchoscopy. METHODS We enrolled patients aged < 18 yr scheduled for rigid bronchoscopy in a prospective observational study. We recorded TcCO2 values from anesthesia induction to the postanesthesia care unit (PACU) stay. We ended monitoring when TcCO2 reached values ≤ 50 mm Hg. The operating room (OR) team was blinded to the TcCO2. The outcome of primary interest was the incidence of hypercapnia (TcCO2 > 50 mm Hg) in the OR. Other outcomes were the incidences of hypercapnia in the PACU and severe hypercapnia (TcCO2 > 90 mm Hg), factors possibly related to hypercapnia (patient, surgery, or anesthesia factors), and the incidence of perioperative adverse events. RESULTS A total of 30 patients were enrolled. The median [interquartile range (IQR)] age was 3.5 [1.5-8.0] yr. The incidence of hypercapnia was 100% in the OR and 60% in the PACU. Five cases (17%) presented with severe hypercapnia in the OR. The highest median [IQR] TcCO2 was 69 [61-79] mm Hg. The most common adverse event was oxygen desaturation (57%, 17/30). Patients with severe hypercapnia had long stays in the PACU. CONCLUSION Hypercapnia was a frequent event in children undergoing rigid bronchoscopy and severe hypercapnia was associated with a long PACU stay. Further studies are needed to assess the utility of TcCO2 monitoring in guiding ventilatory interventions during these cases.
Collapse
Affiliation(s)
- Martina Bordini
- Department of Anesthesia and Pain Medicine, The Hospital for Sick Children (SickKids), Toronto, ON, Canada
- Department of Anesthesiology & Pain Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada
- Department of Medical and Surgical Sciences (DIMEC), Università di Bologna, Bologna, Italy
| | - Julia M Olsen
- Department of Anesthesia and Pain Medicine, The Hospital for Sick Children (SickKids), Toronto, ON, Canada
- Department of Anesthesiology & Pain Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada
| | - Jennifer M Siu
- Department of Otolaryngology-Head & Neck Surgery, The Hospital for Sick Children (SickKids), Toronto, ON, Canada
| | - Jason Macartney
- Department of Respiratory Therapy, The Hospital for Sick Children (SickKids), Toronto, ON, Canada
| | - Nikolaus E Wolter
- Department of Otolaryngology-Head & Neck Surgery, The Hospital for Sick Children (SickKids), Toronto, ON, Canada
| | - Evan J Propst
- Department of Otolaryngology-Head & Neck Surgery, The Hospital for Sick Children (SickKids), Toronto, ON, Canada
| | - Clyde T Matava
- Department of Anesthesiology & Pain Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
- Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.
| |
Collapse
|
300
|
Jameson NM, Kim D, Lee C, Skrable B, Shea A, Guo X, Izadi H, Abed M, Harismendy O, Ma J, Kim DS, Lackner MR. The Selective WEE1 Inhibitor Azenosertib Shows Synergistic Antitumor Activity with KRASG12C Inhibitors in Preclinical Models. CANCER RESEARCH COMMUNICATIONS 2025; 5:240-252. [PMID: 39807828 PMCID: PMC11795354 DOI: 10.1158/2767-9764.crc-24-0411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/06/2024] [Revised: 11/13/2024] [Accepted: 01/10/2025] [Indexed: 01/16/2025]
Abstract
SIGNIFICANCE Resistance to KRASG12C inhibitors is a growing clinical concern. The synergistic interaction observed between azenosertib and multiple KRASG12C inhibitors could result in deeper and more durable responses.
Collapse
Affiliation(s)
| | - Daehwan Kim
- Zentalis Pharmaceuticals, Inc., San Diego, California
| | - Catherine Lee
- Zentalis Pharmaceuticals, Inc., San Diego, California
| | - Blake Skrable
- Zentalis Pharmaceuticals, Inc., San Diego, California
| | | | - Xiao Guo
- Zentalis Pharmaceuticals, Inc., San Diego, California
| | - Hooman Izadi
- Zentalis Pharmaceuticals, Inc., San Diego, California
| | - Mona Abed
- Zentalis Pharmaceuticals, Inc., San Diego, California
| | | | - Jianhui Ma
- Zentalis Pharmaceuticals, Inc., San Diego, California
| | - Doris S. Kim
- Zentalis Pharmaceuticals, Inc., San Diego, California
| | | |
Collapse
|